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Role of C-reactive protein and interleukin-6 in the diagnosis of neonatal sepsis 
Introduction: 
Neonatal sepsis is a major cause of and mortalities in developing countries. Early 
diagnosis and treatment of the newborn infant with suspected sepsis are essential to 
prevent severe and life threatening complications. Early detection of bacterial sepsis is 
difficult for various reasons: firstly, early warning signs and symptoms are often non-
specific. Then there is the difficulty of distinguishing the clinical picture of neonatal 
sepsis from non-infectious causes. Further, microbiological culture results are not usually 
available until at least 48-72 hours after the specimen reaches the laboratory, and high 
false-negative rates of culture results may occur.  
Aims and objectives:  
1. Bacteriological profile of neonatal septicemia and antibiotic susceptibility 
pattern of the isolates. 
2. To determine the value of C-reactive protein and Interleukin-6 in establishing 
the diagnosis of neonatal sepsis. 
Material and Methods: 
Sample size: 100 cases of clinically suspected sepsis cases admitted in Neonatal 
Intensive Care Unit, Tirunelveli Medical College Hospital.  
  Blood samples will be collected from all clinically suspected sepsis cases. The 
samples will be collected under aseptic precaution and all the samples will be analyzed 
by routine blood culture and serum used for detection of C-reactive protein and 
interleukin-6. 
Results: 
 A total of 100 neonates (0 to 28 days) who fulfilled the criteria of clinically 
suspected sepsis were analyzed. Out of 100 study cases, 26 cases were blood culture 
positive. Klebsiella spp were the most common organisms for causing both EONS and 
LONS in the present study. 
 Serum CRP level detected by latex agglutination method had 53.84% of sensitivity 
and 64.86% of specificity against blood culture as a reference test. 
 Serum IL-6 level detected by ELISA had sensitivity of 96.15%and specificity of 
81.08% against blood culture as a reference test. Positive predictive value and negative 
predictive value of IL-6 were 64.1% and 98.36% respectively.  
Conclusion:  
 The findings of the present study confirm that the serum level of IL-6 is a more 
reliable marker than the serum levels of CRP. Serum level of IL-6 is also useful in 
evaluation of response of neonatal sepsis to antibiotic therapy.  
Keywords: Interleukin-6, C-reactive protein, neonate, sepsis, antimicrobial susceptibility. 
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1. INTRODUCTION 
Neonatal sepsis is a clinical syndrome characterized by systemic signs of 
infection, accompanied by bacteremia within the first four weeks of life (28 days). 
Neonatal sepsis is the most common cause of morbidity and mortality in neonatal period.1 
Every year 135 million babies are born alive worldwide. Statistical data in 2011 
estimated 3.0 million of these died during the first four weeks of life.1 
 Neonatal sepsis is classified into early onset neonatal sepsis (EONS) and late onset 
neonatal sepsis (LONS) according to time of onset of signs and symptoms. Early onset 
neonatal sepsis is defined as the onset of signs and symptoms within the first 72 hours of 
life.2  In late onset neonatal sepsis (LONS) clinical signs and symptoms occurs after 72 
hours of age.3 
Early Onset Neonatal Sepsis, which occurs within the first 72 hours of life, usually 
presents with respiratory distress and pneumonia. In severe cases, the neonate may be 
symptomatic at birth.  
Infection may be acquired through the transplacental route during in utero period 
or transcervical route during birth. Ascending infection through the cervix, with or 
without rupture of the amniotic fluid membranes may result in amnionitis, funisitis 
(infection of the umbilical cord), congenital pneumonia and sepsis.4 
Late Onset Neonatal Sepsis  usually presents after 72 hours of age and can either 
be nosocomial (hospital-acquired) or community-acquired infections. The most common 
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cause of late onset sepsis is nosocomial infection from  neonatal intensive care unit. 
Preterm babies and low birth weight infants are mainly affected. The risk factors for late 
onset sepsis are prematurity, low birth weight, male sex, low serum Ig G levels, low 
Apgar scores, mechanical ventilation, prolonged use of intravascular catheters, total 
parenteral nutrition and delayed enteral feedings. These neonates are mainly diagnosed to 
have septicemia, pneumonia or meningitis.5 
 Early diagnosis and prompt and appropriate treatment of all neonates with clinical 
suspicion of sepsis has been found to be an important strategy in preventing neonatal 
mortality and life threatening complications. 
 Initial diagnosis of neonatal sepsis based on clinical signs and symptoms which 
are non-specific as other non-infective condition like aspiration, asphyxia and metabolic 
disorders may also present with similar signs mimicking sepsis. The problem of symptom 
wise false positivity in diagnosing sepsis resulting in unwarranted initiation of empirical 
antibiotic therapy may lead to development of drug resistance, prolonged hospital stayal, 
increased treatment cost and the separation of the neonates from their mothers.  
 Diagnosis of neonatal sepsis is broadly classified into direct method and indirect 
methods. 
Direct method: Isolation of causative microorganisms of sepsis from blood, CSF, urine, 
pleural fluid or pus is diagnostic. 
Indirect method: Over the last decade, a variety of laboratory tests have been developed 
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to enhance the early and accurate identification and treatment of neonates with suspected 
sepsis. Those are haematological markers, serological sepsis markers and radiological 
evidences. 
 The gold standard method for diagnosis of neonatal sepsis is isolation of 
microorganism from blood, CSF, urine and pleural fluid. It is time consuming procedure 
usually takes more than three days for complete result and also requires well equipped 
laboratory and trained personnel for better results. Hence alternative fast diagnostic test 
of serological markers enabling earlier detection of neonatal sepsis might be beneficial. 
 Increased neonatal mortality in neonatal sepsis scenario necessiates need of rapid 
and effective diagnostic test with 100% sensitivity and 100% specificity. Such an ideal 
test is not available at this point of time and yet to be invented. 
 Hence combinations of clinical signs, haematological and serological markers 
have been proved to be a useful strategy in the diagnosis of neonatal sepsis in resource 
poor settings.6 Commonly used diagnostic haematological markers such as total 
leucocyte count, immature: total neutrophil ratio, platelet count, absolute neutrophil count 
and micro erythrocyte sedimentation rate are less sensitive and specific for diagnosing 
neonatal sepsis. 
 In recent days screening of serological markers such as   C-reactive protein (CRP), 
and various cytokines have been suggested as being useful and more sensitive indicators 
for early identification of sepsis in neonates. The biomarkers are classified into early 
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phase marker (Interleukin-6, Interleukin-8, Tumour Necrosis factor-α and Interferon-γ), 
mid phase marker (Procalcitonin) and late phase marker (C-reactive protein).7  
 C-reactive protein (CRP) is an acute-phase protein synthesized by the liver within 
six hours after the onset of inflammation and tissue necrosis. Its rapid synthesis, short 
half-life and  rapid decline with recovery, together with its increase in serious bacterial 
infections, have made the CRP test popular in the diagnosis of infections.8 But it may 
also rise in systemic inflammatory conditions and  giving rise to false positive results 
which limits its usage as specific diagnostic test. 
 Cytokines are main diagnostic markers and their levels are increased first in the 
infectious process. Interleukins are pro-inflammatory cytokines. Interleukins are 
produced by monocytes, activated macrophages and endothelial cells. C-reactive protein 
is induced by interleukin-6(IL-6). 
 Numerous studies have reported on the effectiveness of the quantitative 
measurement of IL-6 for an early diagnosis of neonatal sepsis. 
  Interleukin-6 and Tumour Necrosis Factor –α (TNF-α) are precursors to C-
reactive protein in the inflammatory sequence. These serological markers rise early in 
infection. Hence evaluation of IL-6 alone or with CRP helps in early detection of 
infection and effective management of neonatal sepsis. Interleukin-6 is an early phase 
marker. C-reactive protein is a late phase marker. The purpose of this study is to detect 
the role of CRP and IL-6 in the diagnosis of neonatal sepsis. 
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2. AIMS AND OBJECTIVES 
  
 To detect the bacteriological profile of neonatal sepsis and antibiotic 
susceptibility pattern of the isolates in Tirunelveli Medical College. 
 To determine the value of C-reactive protein and Interleukin-6 in 
establishing the diagnosis of neonatal sepsis. 
 To compare the efficacy of C-reactive protein and Interleukin-6 with 
conventional blood culture method for the diagnosis of neonatal sepsis. 
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3. REVIEW OF LITERATURE 
 Neonatal sepsis is a clinical syndrome characterized by systemic signs of infection 
and isolation of a pathogen from blood, cerebral spinal fluid and from any other sterile 
site with in the first 28 days of life. Bacterial infection is a main cause of neonatal sepsis. 
 It includes various systemic infections of the newborn such as septicemia, 
meningitis, pneumonia, arthritis, osteomyelitis, and urinary tract infections. Superficial 
infections like conjunctivitis and oral thrush are not included under neonatal sepsis.9 
  In developed countries the mortality from neonatal sepsis is found to be in 
declining trend due to improved health care and appropriate use of antibiotics. But, the 
mortality due to neonatal sepsis is still high in developing countries accounting up to 50% 
of neonatal deaths.10 
 Rapid diagnosis and appropriate treatment is very essential in reducing morbidity 
and mortality associated with neonatal sepsis.11  The empiric use of antimicrobial 
treatment to all neonates presenting with clinical symptoms of sepsis practiced in 
resource poor settings in developing countries exposes neonates to adverse drug effects 
and promotes the development of drug  resistant strains.4 
 
3.1 Classification of neonatal sepsis 
 Neonatal sepsis is classified into early onset neonatal sepsis  and late onset 
neonatal sepsis  according to time of onset of signs and symptoms. 
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3.1.1 Risk factors for early onset neonatal sepsis are12 
 Low birth weight – less than 2500 grams or prematurity 
 Febrile illness in the mother with evidence of bacterial infection within two 
weeks prior to delivery. 
 Foul smelling liquor and / or meconium stained liquor. 
 Prolonged rupture of membranes - more than 24 hours. 
 More than three vaginal examinations during lobour. 
 Prolonged labour – more than 24 hours. 
 Perinatal asphyxia. 
3.1.2 Risk factors for late onset neonatal sepsis are5 
 Low birth weight – less than 2500 grams or prematurity. 
 Low Apgar scores. 
 Low Immuoglobulin G (IgG) levels. 
 Prolonged use of intravascular catheters. 
 Treatment with steroids. 
 Total parenteral nutrition. 
 Delayed enteral feedings. 
 Male sex. 
. 
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 The incidences of neonatal sepsis are more common in male infants compared to 
female infants. This male predominance may be due to X-linked immunoregulatory gene 
factor contributing to increased host’s susceptibility to infections in male neonates. 
 A study conducted in Nepal during period of two years from July 2007 to June 
2009 by YR Khinchi AK et al, found that among 175 neonatal sepsis cases, 65.1% were 
male infants and 34.9% were female infants.13 
    Based  on   the  study  conducted   by  Rekha Sriram  et al , Sri Devaraj Urs 
Medical College, Karnataka, India,  out of 115 clinically suspected sepsis cases,  76 
(66.1%) were males and 39 (33.9%) were females. In these 48 cases were cultures 
positive. Among culture positive cases, male infants were 35 (60.3%) and female were 23 
(39.7%). Male infants were predominately affected compared to female infants with a 
ratio of 1.5:1.14 
 A study conducted by Sucila Thangam et al found that among 50 clinically 
suspected neonatal cases, EONS cases were 58% and remaining 42% were under 
category of LONS.16 
 Another study from Tanzaia, during March to November 2009 done  by Neema 
Kayange et al  reported that  60% cases were LONS and 40% cases were EONS among 
300 clinically suspected neonatal sepsis cases.17 
 Recent study done by Flora Chacha et al at Catholic University of Health and 
Allied Sciences, Tanzania during October 2013 to April 2014 revealed among 305 
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clinically suspected sepsis cases, 224 cases (73.4%) were under the age group of 0-3 days 
( less than 72 hours).15 
 The incidence of neonatal sepsis is inversely associated to gestational age. A  
study conducted by Seo et al. revealed that increased sepsis incidence of 16.6% in 
preterm neonates with a gestational age less than 28 weeks and only 0.6% of incidence of 
neonatal sepsis in term neonates.18 
              A study conducted by Rabindra N Misra  et al   over  a  period  of  one year from 
October 2010 to October 2011 highlighted that out of 115 clinically suspected neonatal 
cases, 75 were found to be  culture positive cases.  Among these, 75% of proved sepsis 
cases were preterm and low birth weight neonates. Higher incidence of sepsis in preterm 
and low birth weight neonates are due to inherent deficiency of both humoral and cellular 
immunity during the first week of life.19 
 Long term complications are more in neonatal sepsis of preterm infants compared 
to term infant with neonatal sepsis. A study of Rachel E et al  in Brazil (study period 
2012-2013) reported that neurological complication are 2.5 times more in preterm infants 
with very low birth weight compared to term infants.20 
3.2 Causative organism: 
 The common bacterial isolates for early neonatal sepsis are Klebsiella 
pneumoniae, Staphylococcus aureus and Escherichia coli. In developing countries, 
Staphylococcus aureus is found to be a significant neonatal pathogen isolated from 8-
22% of blood culture. 21 The etiological bacterial agents differ from developed to 
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developing countries.  In 1990, Group B Streptococci was commonest organism for 
EONS in developed countries. Escherichia coli was second common organism.22 
Following Group B Streptococci prophylaxis, developed countries identified gram 
negative enteric pathogens as the most common causative organism.23 
 A study done by Dar es Salaam et al at Muhimbili National Hospital in Tanzania 
found Staphylococcus aureus and Klebsiella species to be the most common causes of 
neonatal sepsis.24 
 A study  carried out in China by Xin-Chuan Chen et al found gram positive 
organism (77.4%) was predominant in neonatal sepsis in Sichuan University.25 
Neelam Kaistha et al conducted study at Government Medical College Hospital at 
Chandigarh (study period July 2003 to October 2007) which revealed that gram negative 
organism were responsible for neonatal sepsis according to 80.40% among 296 positive 
blood culture.26 
 According to a study conducted by Rajlakshmi Viswanathan et al, in Institute of 
Post graduate education and Research and Seth Sukhlal Karnani Memorial Hospital 
Kalkata reported gram negative organism (58%) mainly enteric gram negative bacteria as 
causative organism among 216 neonatal blood culture samples.27 
A study done by Neema Kayange et al  found that among 149 culture positive cases, 
61.1% of sepsis were due to gram negative bacteria. Common bacterial isolates were 
Klebsiella pneumoniae, Escherichia coli and Staphylococcus aureus. More than 50% of 
Klebsiella pneumoniae, Escherichia coli and other gram negative organism were resistant 
to third generation cephalosporins with majority of them Extended Spectrum  Beta 
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Lactamase (ESBL) producer. Among 32 Staphylococcus aureus , 28% of isolates  were 
Methicillin Resistant Staphylococcus aureus.17 
 A study done by Bambala Puthattayil Zakariya et al  in Jawaharlal Nehru Institute 
of Post graduate, Medical Education and Research Puducherry, found  41.6% of blood 
culture positivity. Klebsiella pneumoniae were commonest organism in EONS. Klebsiella 
pneumoniae  and coagulase negative Staphylococcus aureus were mainly responsible for 
LONS. 32% of Klebsiella pneumoniae isolates were found to be ESBL producers. But all 
gram negative isolates were sensitive to meropenem.28 
A study of Iregu KC et al  found that 87% of Klebsiella pneumoniae isolates were found 
to be ESBL producers.29 
 Based on study conducted in North India by Kaistha N et al found that 88% gram 
negative isolates were resistant to gram negative cephalosporin.30 
        Based on the study  conducted by Emily J  Welson et al  at  Centres for Disease 
Control and Prevention, Atlanta and various centre in USA, reported that most common 
organisms were group B Streptococci (37.8%), Escherichia coli (24%), viridans 
Streptococci (18%), Haemophilus influenzae(4%) and Staphylococcus aureus (4%). This 
study showed that group B Streptococci as the commonest pathogen of early onset 
neonatal sepsis.31 
3.3 Pathogenesis of neonatal sepsis 
 The normal amniotic membrane, placenta and amniotic fluid by itself serves as a 
natural protective barrier against infection for inutero fetus by exhibiting anti-microbial 
effects.32  Fetal systemic bacterial infection may occur in preterm and also in term infants 
12 
 
with the neonates presenting symptomatic at birth itself. This infers bacterial infection 
may  occur at inutero stage. Bacterial infection like Listeria monocytogenes is an example 
for transplacental route of infection affecting neonates via maternal circulation.33 
3.3.1Pathogenesis of intrauterine infection 
 Clinical or subclinical maternal infection with agent like cytomegalovirus, 
Treponema pallidum, Toxoplasma gondii, rubella virus, varicella virus and parvovirus 
B19 are transmitted to fetus by haematogenous, transplacental transmission. 
Transplacental infection may occur at any time during pregnancy. Signs of transplacental 
infection may be noticed immediately after delivery or at later periods variable from 
months to years.  Transplacental infection may result in early spontaneous abortion, 
congenital anomalies, intra uterine growth retardation, premature birth, stillbirth or 
asymptomatic persistent infection with sequelae later in life. 
 First trimester infection may affect organogenesis causing congenital anomalies. 
Example is congenital rubella. Last trimester infection frequently results in intra partum 
acquirement of pathogens. In third trimester infection, clinical manifestation occurs 
sometime after birth.  
3.3.2 Pathogenesis of ascending bacterial infection:  
 Intact amniotic membrane serves as natural protective barrier against the inutero 
stage infection of fetus. Some anaerobic and aerobic microbes are found as normal 
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inhabitants of birth passage and those microbes may at times cause ascending bacterial 
infection. 
 Chorioamnionitis is microbial infection of amniotic fluid and chorioamniotic 
membrane. Maternal fever, lower abdominal pain, foul smelling vaginal 
discharge/amniotic fluid, maternal leukocytosis, maternal and/or fetal tachycardia are 
main signs and symptoms of chorioamnioitis. Prolonged rupture of membrane (more than 
24 hour)may cause chorioamionitis and inturn ascending infection. Bacterial colonization 
only does not cause neonatal infection. Prematurity, underlying illness, inoculum size, 
virulence of infecting organism, the innate immune system and transplacental antibodies 
are main factors for early neonatal infection. Aspiration or ingestion of bacteria in 
amniotic fluid, endotracheal intubation, insertion of an umbilical vessels catheter are 
other factors  result in early neonatal sepsis. 
 A study conducted by Pyati et al detected Group B Streptococci sepsis among 
3000 newborn infants. Nearly all with early neonatal sepsis and a birth weight less than 
2000 gram presented with symptoms less than one hour after birth, whereas more than 
two-thirds of those with a higher birth weight developed symptoms later than four 
hours.34 These findings indicate that preterm neonates may be exposed to GBS in utero, 
whereas term neonates often may be exposed during the passage through the birth canal 
and by aspiration of contaminated amniotic  fluid, or by bacteria penetrating through 
injured skin or natural body openings. In most cases this colonisation proceeds without 
causing disease. The mechanism by which bacterial colonisation converts to invasive 
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disease is not fully understood, but it is mainly depends upon bacterial virulence, 
maternal immunological factors, and the competence of the neonatal immune system.35,36 
 In the study of Seo et al, on EONS (culture proven or clinical) found clinical 
chorioamnionitis in 34.7% of preterms with a gestational age less than 28 weeks, among 
22.2% with gestational age 31-33 weeks, and  9.1% of term neonates. Compared to non-
infected deliveries, clinical chorioamnionitis increased the risk of early-onset neonatal 
sepsis 8 to 10 times.37 
3.3.3 Pathogenesis of late onset post natal infection: 
 In late-onset neonatal sepsis, cases are less likely to have a history of obstetric 
complications, and may be infected mainly with nosocomial acquired organisms. Post 
natal infection occurred by direct contact with hospital personnel, the mother, and other 
family members or from inanimate sources such as contaminated equipment.36 
3.4 Immunity: 
 In both term and pre term infants have decreased function of neutrophils, and 
decreased complement level. These factors are mainly responsible for neonatal infection. 
Preterm babies have low immunoglobulin concentration compare to term babies. 
Maternal IgG  antibody is actively transported to fetus  through the placenta. These IgG 
levels are directly proportional to gestational age. Ig M and IgA are not transferred across 
the placenta, although a fetus can synthesize IgM and IgA in response to intrauterine 
infection. Neonatal tetanus and Group B Streptococci infections are prevented by 
15 
 
maternal Ig G antibody.  IgM antibodies are mainly against gram negative enteric 
pathogens. Usually newborn infants lack antibody mediated protection against 
Escherichia coli and other Enterobacteriaceae.  
3.5 Complement: 
 The complement system facilitates bactericidal activity against certain organism 
such as Escherichia coli and functions as an opsonin with antibody in the phagocytosis of 
bacteria such as Group B streptococci. Maternal complement does not cross placenta. A 
fetus begins to synthesis complement components in first trimester itself. Usually term 
newborn infants have slightly diminished classical pathway compliment activity and 
moderately diminished alternative pathway activity.  In comparison to term infant, 
preterm infants have low levels of complement components and less compliment 
activities. These deficiencies contribute to diminished complement derived chemotactic 
activity and to a diminished ability to opsonize certain organisms in the absence of 
antibody. In neonatal infant, opsonization of Staphylococcus aureus is normal, but 
various degrees of impairment have been noted against  Escherichia coli and Group B 
streptococci. 
3.6 Neutrophils: 
 Qualitative and quantitative deficiencies of the phagocyte system mainly 
contribute to neonatal sepsis.  
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Causes for increased susceptibility of neonates to infection are stated as 
1. Abnormal Neutrophil migration at birth in both term and preterm infants. 
Specifically telling decreased adhesion, aggregation and deformability of 
neutrophils may delay prompt response to infection. 
2. Abnormal expression of cell membrane adhesion molecules β2 integrins and 
selectins and abnormalities in neonatal neutrophil cytoskeleton leads to 
abnormal chemotaxis and hence impair response to infection. 
3. Impaired oxidative respiratory burst of neonatal neutrophils aids in increased 
risk of sepsis. 
4. Decreased storage pool of neutrophil - Frequently noticed neutropenia in 
preterm and intra uterine growth retarded infants attributes to the increased risk 
for sepsis. 
3.7 Monocyte – Macrophage system: 
 Prime functions of activated macrophages include antigen presentation, 
phagocytosis and immune modulation. Although count of monocyte in neonatal blood is 
normal, function of macrophages such as impaired chemotaxis increases risk of sepsis. 
3.8 Natural killer cells: 
 Natural killer cells (lymphocyte sub group) are cytolytic against cells infected with 
pathogens. These cells also lyse antibody coated cells and this action is called antibody 
depended cell mediated cytotoxicity (ADCC).  Natural killer cells appear early in 
gestation and are of equalent numbers as in adults. However diminished cytotoxic 
activity and ADCC predispose to increased susceptibility of neonates to sepsis. 
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3.9 Cytokines and acute phase proteins: 
 Cytokines are endogenous chemical mediators that carry information between 
different cells and are important factors in the human inflammatory response. They are 
regulated by a complicated web of regulatory mechanisms including several different cell 
types. In case of infection, both pro-inflammatory and anti-inflammatory cytokines are 
upregulated according to a specific time schedule, and so by studying this upregulation in 
blood samples we can conclude whether systemic inflammation is present or not.  Tumor 
necrosis factor-α (TNFα), Interleukin-1 (IL-1), IL-4, IL-6, IL-8, IL-10, IL-12 and 
platelet-activating factor are important chemical mediators are released in various 
inflammatory reactions. Potential marker for bacterial neonatal sepsis, pneumonia and 
necrotizing enterocolitis are TNFα, IL-6 and IL-8. 
 Inmate immunity also plays an important role against an infectious agent which is 
due to nonspecific cellular and humoral response. Recognition of pathogens is initiated 
by soluble components in plasma (including mannose binding lectin) and by recognition 
of receptors monocyte and other cells. 
Cytokines: 
 Many critical interactions among cells of the immune systems are controlled by 
soluble mediators called cytokines. The cytokines are a diverse group of intracellular 
signaling proteins that regulates not only local and systemic immune and inflammatory 
responses but also wound healing, haematopoises, and many other biological processes. 
Till date, more than 100 genetically unrelated and structurally dissimilar cytokines have 
been identified. Most of cytokines are glycoproteins ad peptides with molecular weights 
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of between 6000 to 60000. They act at very minimal concentrations of 10-10 to 10-15 M. 
So cytokines are highly potent hormone like substances. 
 Biologically active substances secreted by activated T lymphocytes were called  
lymphokines. Monocytes and macrophages produce certain types of cytokines which are 
called as monokines. Some cytokines are normally present in detectable amount in blood 
and are able to control distant target cells. Examples are transforming growth factor β, 
stem cell factor, erythropoietin and monocyte colony stimulating factor. Most of other 
cytokines act either a paracrine manner (act locally near producing cells)or an autocrine 
manner (directly act on producing cells themselves). 
 Each and every cytokine is secreted by particular cell types. In response to specific 
stimuli, these cell types produce cytokines which causes growth, mobility, differentiation 
or functions of its target cells. There is considerable overlap in the effects produced by 
different cytokines. Cloning of cytokines and availability of monoclonal antibodies 
against them has helped to characterize them better. 
3.9.1 Interleukin-1 (IL-1): 
 In 1972, this cytokine was earlier described as leucocyte activating factor, then in 
1974 this cytokine described as B cell activating factor and this cytokine was renamed 
later as interleukin-1in 1979. IL-1 is a stable polypeptide retaining its activity up to 56˚C 
and between pH 3 and pH 11. IL-1 occurs in two molecular forms. They are IL-1α and 
IL-1β. It is principally secreted by macrophages and monocytes but can be produced by 
most other nucleated cells as well. Antigens, inflammatory processes, toxins and injury 
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are stimulating its synthesis. Corticosteroids, cycloserin A and prostaglandins are 
inhibiting its synthesis. 
 Stimulation of T-helper cells  for production of IL-2 and other lymphokine, B cell 
proliferation and antibody synthesis, neutrophil chemotaxis and phagocytosis are main 
immunological effects of IL-1. IL-1 acting on epithelial cells, synovial cells, bone 
marrow, osteoclasts and vascular endothelium which mediating wide range of 
physiological, metabolic, haematological and inflammatory changes. It is one of the 
important endogenous pyrogen.  
 IL-1 and Tumor Necrosis Factor (TNF) are structurally entirely different cytokines 
that binds to different unrelated receptor, but their spectrum of biological effects so 
resemble one another. IL-1 together with TNF is responsible for many of the 
haematological   changes in septic shock and also increases the initial meningeal 
inflammation in bacterial meningitis. Cytokine inhibitors such as corticosteroids have 
been found to protect against the sequelae of such excessive meningeal inflammation. IL-
1 has beneficial   effect in severe infections in immunocompromised hosts.  
3.9.2 TNF: 
 Tumour necrosis occurs in alpha and beta types. This cytokine induces 
hemorrhagic necrosis in certain tumours and was named as the tumour necrosis factor. 
The same substance was independently described as cachectin, a serum factor causing the 
wasting syndrome cachexia during chronic infections.   Cachectin renamed as TNF α. 
Activated macrophages and monocytes are sources of this cytokine. Participation in 
manifestation of endotoxic shock is main immunological activity of this cytokine. 
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3.9.3 IL-1 and TNF: 
 IL-1 and TNF enhance the activation of helper T lymphocytes by antigen 
presenting cells (APC). APCs, on contact with an antigen, secrete IL-1 and TNF. Both 
these cytokines provide co-stimulatory signal that promotes Tcell activation. This appear 
to occur primarily through autocrine effects on the APC itself.  By inducing expression of 
various adhesion molecules, Interferon γ receptors, and class II major histocompatibility 
complex (MHC) proteins of the surface of an APC, IL-6 and TNF increase the efficiency 
with which it can bind and activate T cells. Both IL-6 and TNF can promote nearly all 
types of cellular and humoral responses. 
3.9.4 Interleukin-6: 
        Activated T cells and B cells, macrophages and fibroblasts produce  the IL-6. Main 
functions of IL-6 is synergizing with IL-1and TNF to co-stimulating immune response by 
inducing the acute phase protein in liver cells, stimulating the B cell replication,   
immunoglobulin production and differentiation. Hematopoiesis and thrombopoisis  also 
stimulated by IL-6. IL-6 has antiviral activity and also cross react with some antisera to 
interferon β (IFN β). So it called as interferon β2. 
      The gene for IL-6 is situated on 7 th human chromosome. Molecular weight of IL-6 
ranges from  22000 to 30000.         
 IL-6 has a stimulatory effect on liver cells, nerve cells and hematopoietic cells. 
Therefore IL-6 is main inducer of the hepatic acute phase response mediator in 
host defence against infections.  
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 IL-6 is very effective in increasing TNF or IL-1 induced cachexia and 
glucocorticoid synthesis.  
 IL-6 also stimulates growth of keratinocyte and osteoclastic activities. 
 
            A study conducted by Ng PC et al  revealed that   IL-6 had 89% of highest 
sensitivity and 91% negative predictive  (91%) for detecting late onset infection among 
101 clinically suspected sepsis cases.87 
          Another study from Istanbul University, Turkey done by Emine Kocabas    et al 
showed that IL-6 had 96.2% of sensitivity, 89.7% specificity, 86.2% of  positive 
predictive value and 96.1% of negative predictive value.84 
        A recent study (2013) from Iran, done by Hassan Boskabadi et al  found that IL-6 
had 92.5% of sensitivity, 96.6% of specificity, 97% of positive  predictive value and 93% 
of negative  predictive value.86 
3.9.5 Interleukin-2: 
                    Interleukin-2 is produced by activated T lymphocytes. This cytokine is 
essential for  T -lymphocytes proliferation. IL-2 was first described in 1976 by its ability 
to enhance mitogenesis of human T cells and to support continuous growth of normal T 
cells in culture. So this cytokine is called T cell growth factor. It was an important 
discovery in immunology and it made it possible to propagate and study individual clones 
of normal T lymphocytes that maintain their immunological properties. It converts large 
granular lymphocytes into lymphokine activated killer cells, which can destroy NK-
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resistant tumour cells. This property can be used in the treatment of certain types of 
cancers. IL-2 also stimulates secretion of other lymphokines. 
3.9.6 Interleukin-3: 
        Interleukin-3 is a growth factor for bone marrow stem cells produced by 
 T-lymphocytes. It stimulates multilineage haematopoiesis, and therefore it is also known 
as the multicolony stimulating factor. 
3.9.7 Interleukin-4: 
      Interleukin-4 is produced by T-helper cells. It acts as B-cell differentiating factor, also 
acts as a growth factor for T cells and mast cells and enhances the activity of cytotoxic T 
cells. It increases synthesis of IgG-1 and IgE and play a role in atopic hypersensitivity. 
3.9.8 Interleukin-5: 
      Interleukin-5 is produced by T-helper cells. It causes the proliferation of activated B 
cells and eosinophills and stimulates production of IgA and IgM. 
3.9.9 Interleukin-7: 
      Interleukin-7 is produced by the spleen, bone marrow stromal cells. It acts as B cells 
and T cells growth factor. 
3.9.10. Interleukin-8: 
      Interleukin-8 is produced by macrophages and other cells. It acts as neutrophil 
chemotactic factor. 
3.9.11.Interleukin-9: 
      Interleukin-9 is produced by T-helper cells. It helps in T cells and B cells growth and 
proliferation. 
23 
 
3.9.12.Interleukin-10: 
      Interleukin-10 is produced by T and B cells ad macrophages. It inhibits interferon 
production and functions of mononuclear cells. 
3.9.13. Interleukin-11: 
      Interleukin-11 is produced by bone marrow stromal cells. It induces acute phase 
protein. 
3.9.14.Interleukin-12: 
      Interleukin-12 is produced by T cells. It activates Natural Killer (NK) cells. 
 3.9.15.Interleukin-13: 
      Interleukin-13 is produced by T cells. It inhibits functions of mononuclear cells.38 
Clinical features of bacterial neo natal sepsis: 
3.10. Clinical features of neonatal sepsis:  
 Clinical features of neonatal sepsis are mainly variable. Clinical features of  
neonatal sepsis is divided into non-specific features and  specific features. 
Non-specific features: The earliest signs of sepsis are frequently subtle and nonspecific. 
Clinical diagnosis needs a high index of suspicion for early diagnosis. 
 Clinical features are “hypothermia or fever, lethargy, poor cry, refusal to suck, poor 
perfusion, prolonged capillary refill time, hypotonia, absent neonatal reflexes, 
brady/tachycardia, respiratory distress, apnea and gasping respiration, 
hypo/hyperglycemia and metabolic acidosis”. 
 Early manifestation of neonatal sepsis may involve only one system and present 
with limited symptomatology. Initial signs and symptoms of neonatal sepsis are 
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temperature instability (hypothermia or fever), refusal of feeding and edema.Signs and 
symptoms related to respiratory system are apnea, tachypnea, grunting, cyanosis, 
retractions of chest wall and nasal flaring. Main signs and symptoms related to cardio 
vascular system are pallor, cold and clammy skin, tachycardia (more than 160 beats /min) 
or bradycardia (less than 100 beats /min) and hypotension. Signs and symptoms related to 
central nervous systems are lethargy, irritability tremors, convulsion, abnormal moro 
reflex and hypotonia. Abdominal distension, vomiting, diarrhea and hepatomegaly are 
main signs and symptoms related to gastro intestinal tract. Oliguria is main symptom 
related to renal system. Signs and symptoms related to haematologic systems are 
jaundice, splenomegaly, pallor, petechial purpura and bleeding. Signs and symptoms 
related to skin and soft tissue are impetigo,   omphalitis, scalp abscess, fascilitis, adenitis 
and abscess of cystic hygroma. Most of the times, various non-infectious diseases can co-
exist with neonatal sepsis, which in turn makes sepsis diagnosis a tough one.  Surfactant 
deficiency leading to respiratory distress syndrome can coexist with bacterial 
pneumonia.39 
3.11. Clinical criteria for neonatal sepsis: 
3.11.1. Integrated Management of Childhood Illness criteria: 
 “Tachypnea (> 60 breath per minute), nasal flaring, increased chest retraction, 
grunting, nasal flaring, bulging fontanel, pus draining from ear, redness around 
umbilicus, temperature instability (>37.7˚C or <35.5˚C), lethargic, reduced movements, 
not able to feed and convulsions” are components of integrated management of childhood 
illness criteria for neonatal sepsis. 
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3.11.2. WHO criteria: 
 “Convulsion, tachypnea (> 60 breath per minute), severe chest retraction, 
temperature instability (>37.7˚C or <35.5˚C), lethargic, reduced movements, not able to 
feed, crepitation and cyanosis” are main components of WHO criteria for neonatal 
sepsis.40 
 A study conducted by Jaswal RS et al, in Shimla medical collages India, found 
that the most frequent clinical presentation of neonatal sepsis were respiratory distress, 
lethargy and jaundice with combined frequency of 40% followed by fever and poor 
feeding.41 
 Tanzania based study by Arif SH et al, stated  the most common clinical 
presentation found in neonatal sepsis were fever reported in 91% of neonates, inability to 
breast feed, bulging anterior fontanelle , dyspnea, jaundice, and seizures. Few other 
clinical features of neonatal sepsis included abdominal distension, tachycardia, 
tachypnea, disseminated intravascular coagulopathy    and abscesses.42 
3.12. Diagnosis of neonatal sepsis: 
 Neonatal sepsis is a potentially dangerous and serious condition. That can cause 
increased mortality and morbidity very rapidly, if not treated correctly and quickly.   The 
ideal test to confirm neonatal sepsis   should have 100% sensitivity and 100% specificity. 
But such a test is unlikely to be discovered till date, due to non-specific signs of neonatal 
sepsis. Many signs and symptoms of neonatal sepsis are also present in some of non-
infectious conditions like acute respiratory distress, aspiration of amniotic fluid and 
hypoglycemia etc.43 Hence it remains a challenge for physicians to correctly diagnose 
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neonatal sepsis in a timely manner. So a rapid reliable diagnostic test for neonatal sepsis   
is essential in order to initiate treatment in suspected neonates on time so as to reduce 
associated morbidity and mortality. 
 In routine clinical practice, the recommended approach is to liberally start 
intravenous antibiotics and then perform a ruling out procedure that normally lasts for 
several days. If all the tests for neonatal sepsis are negative and neonate has recovered 
fully, the antimicrobials can be discontinued and infant can be discharged from   the 
neonatal intensive care unit. This rule out procedure normally includes various cultures 
such as blood, cerebrospinal fluid, urine etc, x-rays and various markers of sepsis. If it 
were possible to decrease the time taken by this investigation, the benefits would be 
obvious in terms of reduced costs of treatment, reduced infants suffering and reduced 
duration of antibiotics.  So, there is a great need for specific and less time consuming 
diagnostic methods.  
 A study conducted by Ng PC et al in 2004, presented a list of 58 different 
laboratory tests that had already been evaluated as diagnostic tests for neonatal sepsis.44  
 Another study of review article by Pierrakos et al reviewed 3370 references 
covering 178 biomarkers.45 
3.12.1. Blood cultures: 
 Gold standard diagnostic test for suspected neo natal sepsis is blood culture. A 
small blood volume is enough for isolation of bacteriological agents as low as 0.2 to 
0.5mls. But, increased blood volume 1 to 2mls is required for detection of low 
bacteraemia particularly where there is history of prior use of antibiotics. Venous blood is 
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routinely used for blood culture. The skin should be prepared with disinfectant solution 
before veupuncture. But care must be taken; disinfectant solution does not harm skin of 
newborn infants.46 
 A study conducted in 1997 by Kellogg et al  revealed that low level bacteremia 
was very common in infants. So they recommended a sample volume of 6 ml for to get 
optimize sensitivity. Though, this would represent around 4.5% of an infant’s blood 
volume.47 
 Volume of blood needed for culture depends up methods. Automated blood 
culture systems such as BacT/Alert required small volume of blood such as 0.5ml only. 
But 1-2 ml needed for conventional method.  
 Schelonka RL  et al found that, if one or two viable colony-forming units are in 
the blood inoculated into culture media, the BacT/Alert system will detect growth 
rapidly. Since there appears to be a sizable subset of neonates who are at risk of sepsis 
with a colony count less than 4 CFU/ml, then a 0.5 ml inoculum of blood into the culture 
media is insufficient for sensitive and timely detection of bacteremia. One to two 
milliliters of blood should increase microorganism retrieval in the face of low-colony-
count sepsis by conventional blood culture method.48 
 In developing countries, the conventional type of blood culture method is 
commonly used. Because it is less expensive to do when compared to automated 
culture systems. But the procedure is labour intensive and the yield is significantly low 
sensitivity than that of an automated system.49 In developed countries, automated systems 
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are mostly used. Main advantages of these techniques are the blood culture to be 
monitored continuously and resulting in a shorter time to identify a positive culture.50 
 A study conducted by Baltimore RS et al in Yale University of Medicine, New 
Haevan, USA “found ninety-four cases of non-GBS early-onset sepsis were detected 
between 1996 and 1999. The rate of GBS-related early-onset infection reduced from 
0.61/1000 to 0.23/1000 births, but the annual rate of non-GBS sepsis remained steady, 
ranging from 0.65 to 0.68/1000 during the surveillance period. There was an increase in 
the proportion of Escherichia coli infections that were ampicillin resistant between 1996 
and 1998, but the proportion decreased in 1999”.40 
 A study (during 1998 to 2004) conducted by Ramesh Bhat et al highlighted that 
out of 2182 samples received  from  clinically  suspected  cases of  early onset neonatal 
sepsis   389 (17.8%) showed  positive  blood culture.22 
 A study by  Subhranshu Sekar Kar  et al (2007–2010) revealed  that, among 160  
blood culture samples  tested, 60(16.2%) were blood culture positive. This study was 
done at Hi-Tech medical college, Bhubaneshwar, Odisha.51 
 A study conducted in Kolkatta during March 2009 –August 2010 by Rajalakshmi 
Vishwanathan  et al show 46.3% of positive blood culture in 216 samples.27 
 A study done by Sucila Thangam et al in  Tamiladu during April – September 
2010 revealed 28% of positive blood culture in 50 samples.16 
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  Based on   the study conducted   by  Shrestha R K  et al  in  Nepal medical 
college, Kathmandu, out of 120 suspected cases, 37 (30.8%) were found to be blood 
culture positive during the period of July 2011 to January 2012.52 
 A study conducted by  Neelam Kaistha et al  at Government Medical College 
Hospital, Chandigarh found that 296 (13.17%) blood culture positive among 2247 of 
blood sample from clinically suspected neonatal sepsis.26 
 Even though, if ideal blood volumes are used, blood culture has obvious 
limitations in sensitivity. A negative blood culture report alone cannot support 
withdrawal of antibiotic treatment if the neonate’s clinical condition indicates ongoing 
sepsis.  So blood cultures have limited sensitivity and this method is time consuming, and 
most microbiology laboratories will take one week for complete report.53 
3.12.2. Haematological marker scoring system: 
  This test can be used for screening for neonatal sepsis. It can be performed easily 
and it is readily available in most of the settings. It is usually a combination of various 
parameters from complete blood picture. Various parameters are  
 “Total white blood cell count 
 Absolute Neutrophil count (ANC) 
 Immature Neutrophil : Total Neutrophil Ratio 
 Platelet count 
 Micro erythrocyte sedimentation rate 
 C-reactive protein”.53 
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 In complete blood count, total leukocyte count, neutrophils and platelets are 
predictors of ongoing infection. Ongoing infection interpreted by extreme value of these 
parameters.53,54 
 Non-infectious causes such as asphyxia, maternal fever and post gestational age 
are elevating these parameters. This factors causes difficult in interpretation of results.55 
 Total white cell count alone could not be considered valid for confirmation of 
neonatal sepsis. The reasons being are its grossly varied values and narrow transition 
between normal and abnormal values. Neutropenia is seen more in sepsis rather than 
neutrophila. This neutropenia results from significantly raised adherence of neutrophils to 
surface of endothelial cells and its increased consumption at the area of infection. 
Neutropenia also being noted in certain other condition such as inborn errors of 
metabolism and asphyxia neonatorum makes it of limited value as a sole marker of 
sepsis. Frequently neonatal sepsis is associated with low absolute neutrophils count, and 
high I/T ratio. Low white blood cell count are more helpful if obtained after 4 hours of 
life due to normal increase of white blood cell and neutrophil count after 6 hours of 
life.56,57 
Hematological marker scoring interpretation: 
 “Total leucocyte count: less than 5000/mm3 or more than 30000/mm3 
 Absolute Neutrophil Count (ANC): less than 1000/mm3 
 Immature / Total neutrophil ratio: more than 0.2 
 Micro Erythrocyte sedimentation rate: more than 15 mm in hour. 
 C-reactive protein: more than 1mg/dl”. 
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 If two or more abnormal hematological markers are present, it should be 
considered as a positive screen for neonatal sepsis. If the hematological marker score is 
negative, but clinical suspicion persists, it should be repeated within 12 hours. If the 
hematological markers are still negative, neonatal sepsis can be excluded. Presence of 
two abnormal hematological markers are associated with 93-100% sensitivity, 83% 
specificity, 27% positive predictive value and 100% negative predictive value in neonatal 
sepsis.56 
  Neonatal sepsis also causes thrombocytopenia, because of disseminated 
intravascular coagulation and the damaging effects of endotoxin on platelets. Therefore 
combining the parameter of the complete blood count is the form of a Hematological 
markers Scoring System that has been suggested and can serve as a screening tools.58 
3.12.3. C-Reactive Protein: 
 Tillet and Franchis of Rockefeller University were firstly described C - reactive 
protein. They demonstrated a precipitation reaction with polysaccharide fraction C from 
the peumococcal cell wall and serum of patient suffering from peumococcal pneumonia. 
Serum of healthy controls and some pneumococcal  pneumonia recovered  patients does 
not show this precipitation.  In interpretation of the fact that the polysaccharide fraction 
was a protein, the C-reactive component in the serum was named C-reactive protein.59 In 
1950, CRP had been detected in more than 70 various disorders including acute bacterial, 
viral, and other infections, as well as noninfectious diseases such as, rheumatic disorders, 
acute myocardial infarction, and various malignancies.  All of these disorders of different 
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etiology had in common the factor of inflammation and/or tissue injury. Increased serum 
level of CRP is very early and sensitive response to most of microbial infections.60 
         C- reactive protein (CRP) is one of the acute-phase proteins.  It belongs to the 
pentraxin family of ligand-binding and calcium-dependent plasma proteins. In acute 
infection, serum level of CRP increased up to 50 to 100 mg/L. But in chronic condition 
like rheumatoid arthritis and atherosclerosis its level generally remains below 10 mg/L.61 
Synthesis and metabolism: 
 Hepatocytes are main site for production of CRP. CRP synthesis and secreted 
depends upon various response to cytokines such as Interleukin-6, Interleukin-1 and 
Tumour Necrosis Factor-α (TNF-α). CRP is primarily derived via IL 6- dependent 
hepatic biosynthesis. Increased CRP level in neonate always represents endogenous 
synthesis. CRP passes through the placenta is very very minimal. Only single stimuli 
enough to hepatic synthesis of CRP, that increase the serum concentration above 6mg/l 
by about 6 hours and peaking at around 48 hours.62 
 The stimulatory effects of cytokines on the production of acute phase proteins 
increased by glucocorticoids.63  Insulin, on the other hand, decreases their effects on the 
production of some acute phase proteins.64,65  
CRP detection method: 
 A large number of methods are available for the detection of CRP and estimation 
of CRP  level in the serum. Even though, nephrometry, electroimmunoprecipitation assay 
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and  immunometric assay  are sensitive and quantitative method for the estimation of 
CRP. These methods have complicated procedure, so these tests done only well-equipped 
laboratories only.60  Latex agglutination test is the alternative test, it have a quiet 
sensitive, rapid method to detect serum CRP in qualitatively and semi quantitatively. The 
serum CRP concentration of 6mg/L or more was considered as positive.(15) 
Function of C-reactive protein: 
 The main receptor to CRP is phosphocholine. Phosphocholine is found in 
lipopolysaccharide of bacterial cell wall and in most of biological membrane. CRP and 
phosphocholine binds first, after that CRP is recognized by the complement system. CRP 
activates the complements system and promotes the phagocytosis by neutrophils and 
macrophages. Then CRP initiates release of proinflammatory cytokines.70,71 
 The sensitivities and specificities of CRP assay in the detection of neonatal sepsis 
using culture as a gold standard. Sensitivity of CRP is more important than specificity in 
detection of EONS and LONS. 
 Condition where CRP is elevated: 
 CRP level is increased in some acute conditions such as bacterial infection, 
bacterial endocarditis, pneumococcal pneumonia and acute rheumatic fever. CRP level is 
increased  in more number of chronic condition like polyarthritis nodosa,  rheumatoid 
arthritis, systemic lupus erythematosis,  Inflammatory bowel disease, acute myocardial 
ischemia and malignancies etc.65 
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 A study conducted by Benitz MD  et al from Stanford University of Medicine 
shows 54.6% of sensitivity on proven neonatal sepsis and 65.5% of sensitivity in 
probable neonatal sepsis among 1002 infants. The positive predictive value was 99.7% 
and negative predictive s for CRP was 98.7% for  conformed neonatal sepsis. 66 
 Laborada  G  et al revealed that during study (2003), out of 105 neonatal sepsis 
cases blood culture  tested  48 cases were  positive by automated technique. This study 
also shows 69% sensitivity , 96% specificity, 93% positive predictive value and 80% 
negative predictive value.67 A  similar  study  by    Doellner H  et al reported  that CRP 
sensitivity 63%, specificity 97%, positive predictive  83% and negative predictive value 
91%. Doellner H et al study also include 36 samples are positive among 253 blood 
culture.68 
 According to a study conducted by Franz A R et al revealed that 46 cases are 
culture positive among 162 neonates with suspected sepsis and also reported 28% of CRP 
sensitivity, 97% of specificity, 81%  of positive predictive  and 77% of negative 
predictive value.69 
 Neonates with septicemia due to gram negative organism have higher serum CRP 
level than gram positive organism.72 
  Recent study by Flora Chacha et al  highlighted that out of 305 samples received  
from  clinically  suspected  cases of neonatal  over  a  period  of  2  years, 104 cases  
showed  CRP positive. This study also revealed CRP sensitivity 90% , among these 75% 
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higher  sensitivity for gram negative septicemia compare to  50% sensitivity for gram 
positive septicemia.15 
 A study conducted  in Thailand by Nuntnarumit P et al found that serial 
quantitative CRP measurement were found to have better predictive  than complete blood 
count with 100% sensitivity, 94% specificity, 91% positive predictive  and 100% 
negative predictive. 73 
 A study was done in Rawalpindi Pakistan by Khassawneh  M  et al,    comparing 
CRP, absolute neutrophil count and I/T ratio, CRP was found to have a specificity of 
95% in diagnosing neonatal sepsis followed by absolute neutrophil count.74 
  A study conducted by Kohli-Kochhar R et al, in   Port Harcourt Nigeria, the 
sensitivity, specificity, positive predictive value and negative predictive  of serial CRP 
measurements were found to be 74.0%, 74.1%, 68.0% and 79.0% respectively in the 
diagnosis of neonatal sepsis using blood culture as the gold standard.75 
 In a study done by Hofer N et al, comparing CRP, interleukin 6 and 
immunoglobulin M; revealed that CRP was the best among the three with 95% sensitivity 
and 98% NPV in the diagnosis of early gram negative sepsis.76 
 Serial serum CRP measurements taken between 24 and 48 hours after the onset of 
infection have been found to have high sensitivity for probable septicemia. Hence serial 
CRP is suggested for the diagnosis of neonatal sepsis to predict early infection.77 The 
neonates who were admitted with clinical features of neonatal sepsis and started on 
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empirical treatment with antibiotics following the negative results of CRP, the physician 
can stop the antibiotics thus can minimize antibiotic exposure and shorten hospital stays. 
The diagnostic value of serial measurements of serum CRP levels can also be used for 
monitoring the severity of sepsis and improvement after initiation of treatment.78 
3.12.4. Procalcitonin: 
 Procalcitonin is an another acute phase protein which is   made up of  116 amino 
acids. It is a precursor of calcitonin. Within 6-8 hours of bacterial infection, bacterial 
endotoxin stimulates monocytes and hepatocytes which produce procalcitonin.  Its level 
reaches peak at 6 – 8 hours, and stays minimum for a day. It half-life is upto 30hours. 
Procalcitonin level is increased during infection in neonates, children and adults. Serum 
procalcitonin level is more increased in bacterial infection than in viral infection. In early 
neonatal bacterial infection, procalcitonin is more sensitive than CRP.79 Serum 
procalcitoin level also increased in some non-infectious condition such as neonates with 
respiratory distress syndrome, haemodynamic instability and diabetic mothers.79 
  A study done by Cetinkaya M et al, during the period of 2008-2009 found that the 
serum procalcitonin levels were higher in the neonatal septic cases compared with the 
non-septic cases. This also revealed procalcitonin and CRP had sensitivity of 97%, 
specicity of 91%, positive predictive value 96% and negative predictive value of 87%. 
The inference was procalcitonin  more than 2.3 ng/ml or CRP more than 30 mg/l denotes 
a possibility of EONS and LONS. In such condition antimicrobial treatment need to be 
carried over in the absence of positive culture. 80 
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3.13. 1.Prevention strategies for EONS: 
 Prior administration of parental antibiotics to antenatal mothers prevents EONS by 
group B Streptococci to a great extent. Ampicillin or cefazolin are used as 
prophylactically four hour before delivery. In mother who have mild pencillin allergy, 
cefazolin may be administrated. In case of serious pencillin allergy, clinadamycin is the 
drug of choice. In clindamycin resistant cases, vancomycin is used as an alternative drug 
for prophylaxis.81 
Indications for intranatal antibiotics are  
 Positive antenatal culture for group B streptococci 
 Premature rupture of membranes. (>18 hours) 
 Previous infection with group B Streptococci. 
3.13.2.Prevention strategies for LONS: 
 To provide practical training for hand washing technique for entire health care 
team. 
 To provide adequate soap and running water facilities. 
 To prepare standard operating procedure for all invasive methods. 
 To carry out regular meeting with infection control committee to monitor infection 
rate. 
 To ensure the adequate of physicians and nurses per bed according to current 
recommendations.81 
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4. MATERIALS AND METHODS 
         The present study was conducted at the Department of Microbiology , Tirunelveli 
Medical College , Tirunelveli from  Jauary 2015 to August 2015.  
4.1 Study group 
         A total of 100 clinically suspected sepsis cases in neonates (0 day to 28 days) 
4.2. Inclusion criteria  
 Neonates who were admitted in Neonatal Intensive Care Unit at Tirunelveli 
Medical College with signs  suggestive of sepsis, or those who developed signs of 
sepsis while they were in the ward. 
4.3. Exclusion criteria:  
 Neonates who were on antibiotics, 
 Neonates who had birth asphyxia and aspiration syndromes, 
 Neonates who had congenital anomalies and inborn errors of  metabolism. 
4.4. Ethical clearance 
 Ethical clearance was obtained from the college ethical committee before the 
commencement of the study. 
4.5. Consent 
 Informed consent was obtained from reliable informants of neonates who 
participated in the study. 
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4.6. Proforma: 
 The proforma was filled with the details like name of mother of neonates, age (in 
hours or days), sex, weight of neonates at time of birth, gestational age (in weeks), mode 
of delivery and clinical diagnosis and other parameters relevant to the present study. 
 
                                                    4.7.  METHODS 
 Blood samples were taken from 100 clinically suspected neonatal sepsis and were 
tested for blood culture, detection of serum level of CRP by latex agglutination test and 
detection of serum level of IL-6 by ELISA. 
4.7.1. Blood collection method: 
 Ideal blood sample collection should be done before initiation of anti-microbial 
agents. 
Volume of blood needed for culture 
 Amount of blood needed for cultures for neonates is significantly lower than that 
needed for adults because neonates tend to have a higher concentration of bacteria in their 
bloodstream than adults. Hence 2ml of  blood  was usually considered as the standard 
volume of blood adequate to detect bacteremia in neonates. 48 
 Proper aseptic precautions were undertaken during blood specimen collection to 
 avoid sample contamination.  
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 With clean gloved hands, preliminary aseptic  precautionary steps like cleansing 
the venipuncture site with 70% ethanol and 2% tincture iodine and proper drying 
were followed. 
 Then using a 2ml syringe with a 28G needle  about 2-3 ml of blood was aspirated.  
Immediately and without changing or contaminating the needle 2 ml of blood 
sample was transferred into the top of the blood culture bottle that contains 20ml 
brain heart infusion broth. (HiMedia, India) 
 Another 1 ml of blood was collected in serum separating vial.  
 Sharps were disposed in a sharps container. 
 The culture blood was gently mixed  and labelled.  
 The inoculated bottles were sent to the laboratory immediately. 
 The collected samples were subjected to various  laboratory studies. 
 
4.7.2. Storage of serum sample: 
 Blood samples were centrifuged within 30 minutes of collection. Serum samples 
were immediately tested for CRP by latex agglutination method and then stored for IL-6 
ELISA at -80 o C. 
4.7.3. Blood culture processing procedure: 
 Inoculated culture bottle was incubated at 37˚C for up to 7 days. Subsequent sub 
culture was done in solid agar plates such as blood agar plate, chocolate agar plate, Mac 
conkey agar plate and nutrient agar plate after 24 hours and 72 hours with last subculture 
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being done after seven days. Subculture blood agar plate, Mac Conkey agar plate and 
nutrient agar plate were incubated aerobically and chocolate agar plate was incubated in 
carbon dioxide atmosphere for 24 hours. 
4.7.4. Identification of microorganism: 
 The isolates were routinely identified by standard bacteriological techniques. 
 Morphology of colonies on nutrient agar plate, Mac Conkey agar plate and blood 
agar plate were studied. 
 Mac Conkey agar plate was used to differentiate lactose fermenting from non-
lactose fermenting organisms. Lactose fermenting organism such as Escherichia 
coli and Klebsiella species which produced pink colour colonies were isolated. 
Non -lactose fermenting organism such as Pseudomonas  species which produced 
colourless colonies were isolated. 
 Blood agar plate was used to differentiate α-haemolytic from β-haemolytic 
organisms. Staphylococcus aureus producing β-haemolysis were identified. 
 Using nutrient agar plate Staphylococcus aureus producing golden yellow colour 
colonies and Pseudomonas aeruginosa producing metallic shin along with bluish-
green diffusible pigment were identified. 
 Using gram stain, gram positive (Staphylococcus aureus) and gram negative 
(Escherichia coli,  Klebsiella species and Pseudomonas aeruginosa) organism 
were differentiated. Shape and arrangements of organism whether cocci or bacilli 
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and in pairs, chains or clusters were studied. Colonies were further tested for 
catalase, oxidase and motility tests.  
 Motile organisms such as Escherichia coli and Pseudomonas aeruginosa and non-
motile organism such as  Klebsiella species were identified. 
 Biochemical tests such as indole test, methyl red test, Voges-Proskaeur test, Triple 
Sugar Iron test, citrate utilization test, various sugar fermentation test and 
Oxidation-Fermentation test (OF Test) were used to differentiate organisms 
among Enterobacteriaceae family and pseudomonas spp.90 
 Some specific test like catalase test, coagulase test and phosphatase test for 
Staphylococcus aureus were done. 
All blood samples were subjected to the above said various tests and causative 
organisms for neonatal sepsis were identified.90 
4.7.5. ANTIBIOTIC SUSCEPTIBILITY TESTING: 
 The antibiotic susceptibility testing was done in all isolates by Kirby Bauer disc 
diffusion method according to the CLSI guideline. 
 Kirby-Bauer’s disc diffusion method: 
        About 3-5 colonies of the test organism were inoculated in 2 ml of peptone water 
and incubated for 2-4 hours at 37˚C. The turbidity of the inoculum was adjusted to 0.5 
McFarland standards (1.5x108 CFU/ ml). A sterile cotton swab was soaked in the 
inoculum and a lawn culture was made on to the Muller-Hinton agar (MHA). By rotating 
the swab against the inner side of the test tube, excess broth was expressed. The panel of 
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antibiotic discs was applied and incubated at 37˚C for 18-24 hours. The zone size was 
recorded and interpreted as per the CLSI guidelines 2013.  
The three interpretive categories are described as follows. 
Susceptible: 
 This indicates that the recommended antibiotic in appropriate dose for 
recommended period is the appropriate agent for treating the infection. 
Intermediate: 
 This indicates that the tested organism may be inhibited by possible concentrations 
of certain drugs if higher concentrations of the drug can be used safely. 
Resistant: 
 The antibiotic tested may not be an appropriate choice for the infection against the 
tested organisms either they are not inhibited by the concentration of the drug normally 
achievable with the recommended dose or because the test result vastly correlates with a 
resistance mechanism. 
 In this study the susceptibility for the organism was tested against following 
antimicrobials from Hi-media laboratories Ltd, Mumbai. 
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Interpretation of Antibiotic susceptibility testing 
Antibiotic Concentration 
(in μg)  
Sensitive 
(in mm) 
Intermediate 
 (in mm) 
Resistant 
(in mm) 
Ceftriaxone 30 >23 20-22 <19 
Cefotaxime  30  >26 23-25  <22  
Ceftazidime  30  >18  15-17  <14  
Gentamicin  10  >15  13-14 <12  
Amikacin  30  >17  15-16  <14  
 Ciprofloxacin  5  >21  16-20  <15  
Ofloxacin 5 >17 14-16 <13 
Meropenem 10 >19 16-18 <15 
Pip – Tazo 100 >21 15-20 <14 
Ampicillin 10 ≥18 14-17 ≤13 
Cefoxitin 30 ≥18 15-17 ≤14 
Vancomycin 30 ≥15   
 
  Gentamycin, amikacin, cefotaxim, ceftazidime, ciprofloxacin are first line drugs 
for gram negative organisms.  Imipenem, meropenem and cefaperazone-sulbactum are 
reserved for second line drugs.  
 Ceftazidime (30µg) and ceftazidime – clavulanic acid (30µg / 10µg)  disks were 
used for detection of extended spectrum β-lactamase (ESBL) in enterobacteriaecea. The 
above said both disks were placed 20 mm apart in Mueller-Hinton agar and incubated at 
37˚C for 24 hours. A zone size ≥5mm in  ceftazidime – clavulanic acid combination disk 
compared to ceftazidime alone disk was interpreted as positive for ESBL production.  
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 Ampicillin, cefoxitin gentamicin, amikacin, ciprofloxacin and vancomycin were 
tested for gram positive organism. Pencillin and Cefoxitin  disc were used for detection 
of Methicillin Resistant Staphylococcus aureus (MRSA). 
4.8. Serum CRP level detection by latex agglutination test: 
 All  the  100  samples  were  tested  for CRP detection by  latex agglutination test 
with the help CRP test kit of SPAN DIAGNOSTICS LTD, INDIA  
4.8.1. Principle: 
 Specially selected polystyrene latex particles are coated with monospecific goat 
anti human CRP antibodies. When a serum positive for C - reactive protein is mixed 
with the latex reagent, a positive result is indicated by a distinctly visible agglutination 
of the latex particles in the test cell of the slide used. In specimen negative for C – 
Reactive Protein, the latex remains in a smooth suspension form in the test cell. 
4.8.2. Materials provided: 
 C - reactive protein latex agglutination test kit contains the following items to 
perform the assay.  
 Latex reagent for tests – Suspension of polystyrene latex particles, coated with 
monospecific goat anti-human CRP antibodies. 
 Positive Control serum – 0.5ml 
 Negative Control serum – 0.5 ml 
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 Disposable slides with 8 test cells. 
 Disposable mixing sticks. 
 Disposable plastic droppers with a rubber teat. 
4.8.3. Storage 
 C-Reactive Protein latex agglutination kit was stored at 2-8 ˚C. 
4.8.4. Test procedure: 
Qualitative analysis: 
 The latex reagent, controls and serum specimens were brought to room 
temperature. The antigen suspension was mixed thoroughly prior to use. 
  One drop each of patient serum,  positive and negative control sera were placed in 
respective cells of the test plate. 
 Then  one drop each of CRP latex reagent was added  to each of these sera. 
 The sera and  latex reagent were mixed with separate mixing sticks and  the fluid 
spread over the entire area of the particular cells. 
  The test slide was tilted back and forth for two minutes so that the mixture rotates 
slowly inside the cells . 
 At the end of two minutes  the results were read under bright light. 
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4.8.5. Interpretation of results: 
 Strong Positive – Distinct coarse agglutination occurs within 0.5 minute. 
 Weakly Positive – Fine agglutination usually taking full 2 minutes. 
 Negative - No agglutination. 
 Distinct agglutination indicates CRP content of more than 6 mg/litre in undiluted 
serum specimen. Sera with positive results in the screening were tested in the titration 
test. 
4.8.6. Semi quantitative analysis: 
  0.9% saline solution was prepared. Then the  specimen was diluted with saline 
until the last diluttion giving distinct agglutination. 
Dilution CRP (mg/litre non-diluted specimen) 
1:2 12 
1:4 24 
1:8 48 
1:16 96 
1:32 192 
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 Titre is the  last dilution step giving visible agglutination. Read the titre in the last 
dilution step with agglutination and multiply the titre with the conversion factor 6 to get 
the results in mg/litre. 
  With the above standard guidelines, samples were tested and obtained results 
were  documented. 
4.9. Serum IL-6 level detection by ELISA: 
 All the 100 samples were tested for IL-6 detection by ELISA with the help of 
DIACLONE SAS, FRANCE ELISA test kit. 
4.9.1. Principle of the method: 
 A capture antibody highly specific for Interleukin-6 has been coated to the wells 
of the microtitre strip plate provided during manufacture. Binding of IL-6 samples and 
known standards to the capture antibodies and subsequent binding of the biotinylated 
anti-IL-6 secondary antibody to the analyte is completed during the same incubation 
period. Any excess unbound analyte and secondary antibody is removed. The HRP 
conjugate solution is then added to every well, following incubation excess conjugate is 
removed by careful washing. A chromogen substrate is added to the wells resulting in the 
progressive development of a blue coloured complex with conjugate. The colour 
development is then stopped by the addition of acid turning the resultant final product 
yellow. The intensity of the produced coloured complex is directly proportional to the 
concentration of  IL- 6 present in the samples and standards. The absorbance of the 
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colour complex is then measured and the generated OD values for each  standard are 
plotted against expected concentration forming a standard curve. This standard curve can 
then be used to accurately determine the concentration of IL – 6 in any sample.    
4.9.2. Materials provided: 
 A capture antibody highly specific for IL-6  Coated Microwells(12×8 wells) 
 Biotinylated anti-IL-6 – 0.4ml X 1 
 Biotinylated Antibody diluent – 1 X 7 ml.                                                                 
 Streptavidin – HRP : 2 x 5 µl 
 HRP Diluent : 1x23 ml 
 TMB Substrate. 
 Stopping solution:1.6 N sulfuric acid. 
 Standard : 200pg/ml. (2 vials) 
 Standard Diluent:  1x7ml. 
 Control: 2 (Freeze dried powder form). 
 Washing Buffer: 200x concentrate dilute in distilled water. 
4.9.3. Material required: 
 Microtitre plate reader with appropriate filters (450 nm required with optional 
 620nm reference filter). 
 Microplate washer 
 10, 50, 100, 200 and 1000µl  adjustable single channel micropipettes with 
 disposable tips. 
50 
 
 50 -300 µl multi-channel pipette and reagent reservoirs. 
 Distilled water. 
 Vortex mixer. 
4.9.4. Kit storage: 
 Store kit reagents between 2 and 8˚C. Immediately after use remaining reagents 
should be returned to cold storage (2-8˚C). 
Preparation of Standard : 
  Standard vials must be reconstituted with 770 µl of standard diluent on the vial 
immediately prior to use. This reconstitution gives a stock solution of 200pg/ml of IL-6. 
Mix the reconstituted standard gently by repeated aspiration. Serial dilutions of the 
standard are made directly in the assay plate to provide the concentration range from 200 
to 6.25pg/ml. 
 Immediately after reconstitution add 200µl of the reconstituted standard to well’s A1, 
which provides the highest concentration standard at 200pg/ml. 
 Add 100µl of appropriate standard diluent to the remaining standard wells B1 to F1. 
 Transfer 100µl from wells A1 to B1. Mix the well contents by repeated aspirations 
and ejections taking care not to scratch the inner surface of the wells. 
 Continue this 1:1 dilution using 100µl from wells B1 through to F1 providing a serial 
diluted curve ranging from 200pgml to 6.25pg/ml. 
 Discard 100µl from the final wells (F1) of the standard curve. 
 
 
51 
 
4.9.5. Preparation of Controls: 
  Freeze-dried control vials should be reconstituted with 1ml of standard diluent – 
Human serum. This is used as Positive control (G1). Only 100µl of standard diluent -  
Human serum used as Negative control. 
Preparation of Biotinylated anti-IL-6: 
 Biotinylated anti-IL-6 is prepared immediately before use. Dilute the biotiylated 
anti-IL-6 with the biotinylated antibody dilute in an appropriate  clean glass vial 
using volumes appropriate to the number of required wells.  
No. of wells required Biotinylated Antibody 
(µl) 
Biotinylated Antibody 
Diluent (µl) 
16 40 1060 
24 60 1590 
32 80 2120 
48 120 3180 
96 240 6360 
 
4.9.6. Preparation of Streptividin - HRP 
 To centrifuge vial of Streptovidin-HRP vial for a few seconds in a 
microcentrifuge to collect all the volume at the bottom. Then the  5 µl vial with 
0.5ml of HRP diluent immediately before use. Further dilute the HRP solution to 
volumes appropriate for the number of required wells in a clean glass vial.  
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No. of wells required Streptavidin – HRP 
 (µl) 
Streptavidin – HRP 
Diluent (ml) 
16 30 2 
24 45 3 
32 60 4 
48 75 5 
96 150 10 
 
4.9.7. Preparation of wash buffer: 
  Dilute the (200x) wash buffer concentrate 200 fold with distilled water to give a 1x 
working solution. Pour entire contents of the washing buffer concentrate into 2000 ml 
graduated cylinder. Bring final volume to 2000 ml with distilled water. Mixed gently to 
avoid foaming. Transfer to a clean wash bottle and store at 2˚-25˚C. 
ELISA Procedure: 
 Add 100µl of each, standard, positive control, negative control and sample to 
appropriate number of wells. 
 Add 50µl of diluted biotinylated anti-IL-6 to all wells. 
 Cover with a plastic plate cover and incubate at room temperature (18 to 25˚C) for 
one hour. 
 The wells were washed 3 times with diluted washing solution using an 
automatic washer. 
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 Add 100µl of Streptavidin-HRP solution into all wells. 
 Cover with a plastic plate cover and incubate at room temperature (18 to 25˚C) for 30 
minutes. 
 The wells were washed 3 times with diluted washing solution using an automatic 
washer. 
 Add 100µl of ready to use TMB substrate solution into all wells. 
 Incubate in the dark for 15 minutes at room temperature. Avoid direct exposure to 
light by wrapping the plate in aluminium foil. Blue colour developed in the wells. 
 Add 100 μl  of stopping solution was pipette into each wells and mixed well and the 
blue colour changed to yellow. 
 The absorbance of each well was read within 30 minutes at a wavelength of 450nm 
with a reference filter of 620nm. 
4.9.8. Data analysis: 
  Calculate absorbance values of standards, controls and samples. Generate a linear 
standard curve by bloating the average absorbance of each standard on the vertical axis 
versus the corresponding IL-6 standard concentration on the horizontal axis. The amount 
of IL-6 in each sample is determined by extrapolating OD values against IL-6 standard 
concentrations using the standard curve.  
    
 
 
54 
 
 
5.  RESULTS 
 
5.1 The  Study  Group 
               A total of 100 neonates (0 to 28 days) who fulfilled the criteria of clinically 
suspected sepsis were analyzed. This study  was  conducted  at  the  Department  of  
Microbiology ,  Tirunelveli  Medical College  Hospital, Tirunelveli  over  a  period  of  
one  year  from  January 2015 to  August  2015.  
5.2 Statistical Analysis 
              All  the  results  obtained  were  analyzed  statistically  for  their  completeness ,  
consistency  and  accuracy  by  the  parameters  like  mean  and  percentages. Kappa 
value was calculated to measure the degree of agreement between three diagnosis 
methods- Blood culture with CRP and Blood culture with IL-6. The correlation of serum 
CRP level and Interleukin-6 level with blood culture for neonatal sepsis was compared 
statistically and results were analyzed by  IBM SPSS Statistics 20. Chi-square test and 
Fisher Exact test were used in calculating the P-value. The  P-Values  of  less  than  0.05 
were  considered  as  statistically  significant (P<0.05). 
5.3 Result Analysis:     
            The  selected  100  study  subjects  were  analyzed  based  on  age  and  sex, The  
results  of  the  analysis  are  tabulated  in Table 1.                       
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Table 1.Age and sex wise distribution in study group 
Age 
 (in days) 
           Male          Female          Total 
No. % No. % No. % 
EONS  
(0-3 days) 
30 51.72% 28 66.67% 58 58% 
LONS  
(4-28 days) 
28 48.28% 14 33.33% 42 42% 
Total 58 100% 42 100% 100 100% 
 
 Figure 1: 
  
The above table:1 and figure:1 shows that among the 100 neonates, 58 were male infants 
and 42 were female infants. Male and female ratio was 1.38:1.  
 
MALE FEMALE
58
42
Male and  Female ratio 1.38 : 1
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Figure  2. Age and sex wise distribution in study group. 
 
 
 
 Out of the 100 neonates, 58 (58%) were in the age group of 0-3 days and these 
neonatal sepsis are called as early onset neonatal sepsis (EONS). In EONS, 30 cases are 
male and 28 female cases. 
 The remaining 42 (42%) were in the age group of 4-28 days and these neonatal 
sepsis are called late onset neonatal sepsis (LONS). In LONS, 28 cases are male and 14 
female infants. (Table 1 and Figure 2). 
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Table: 2 
 Birth weight wise distribution in study group 
 
 
 
Birth weight 
 
 
EONS 
 
LONS 
 
TOTAL 
 
No. 
 
% 
 
No. 
 
% 
 
No. 
 
% 
 
Normal Birth weight 
(≥ 2.5 Kgs) 
 
 
34 
 
58.6% 
 
6 
 
14.3% 
 
40 
 
40% 
 
Low Birth weight 
 (< 2.5 Kgs) 
 
 
24 
 
41.4% 
 
36 
 
85.7% 
 
60 
 
60% 
 
 
Total 
 
 
58 
 
100% 
 
42 
 
100% 
 
100 
 
100% 
 
  
 The   table : 2  and figure : 3 shows that  out  of  100  cases  studied , 40% of 
neonates were of  normal birth weight ( ≥ 2500 gms) and 60% of neonates were of  low 
birth weight      ( <2500 gms). 
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Figure : 3 
 
 
 Among 58 cases of EONS, 34 (58.6%) cases were normal birth weight and 24 
(41.4%) cases were low birth weight. 
 Among 42 cases of LONS, 36 (85.7%) cases were found low birth weight only 6 
cases  (14.3%) were normal birth weight. 
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Table :   3  Gestational age wise distribution in study group  
 
 
 
Gestational age 
 
 
EONS 
 
LONS 
 
 
 
TOTAL 
 
 
 
No. 
 
 
% 
 
No. 
 
% 
 
No. 
 
% 
 
Preterm 
(< 37 weeks) 
 
 
 
 
17 
 
29.3% 
 
 
29 
 
 
69.1% 
 
 
46 
 
 
46% 
 
Term 
( completed 37 
weeks) 
 
 
 
41 
 
 
70.7% 
 
 
13 
 
 
30.9% 
 
 
54 
 
 
54% 
 
 
Total 
 
 
 
 
58 
 
 
100% 
 
 
42 
 
 
100% 
 
 
100 
 
 
100% 
 
 The  above table :3, figure :4   shows that  out  of  100  cases  studied , 46% of 
neonates were found to be preterm (< 37 weeks of gestation) and 54% of neonates were 
found to be term neonates ( completed 37 weeks). 
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Figure :4 
 
 
 Among 58 cases of EONS, 17 (29.3%) cases were found to be preterm and 41 
(70.7%) cases were term neonates. 
 Among 42 cases of LONS, 29 (69.1%) cases were found to be preterm and 13 
cases  (30.9%) were term neonates.( Table : 3 and Figure:4) 
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Table : 4      Mode of delivery among study group 
 
 
 
Mode of delivery 
 
 
 
EONS 
 
 
 
 
LONS 
 
 
 
 
TOTAL 
 
 
 
No. 
 
 
% 
 
No. 
 
% 
 
No. 
 
% 
 
Assisted  
 
 
8 
 
 
13.8% 
 
0 
 
 
0% 
 
8 
 
8% 
 
 
Lower segment 
Caesarean 
Section 
 
 
 
27 
 
 
46.6% 
 
 
15 
 
 
35.7% 
 
 
42 
 
 
42% 
 
Normal 
 
 
23 
 
39.6% 
 
27 
 
 
64.3% 
 
50 
 
50% 
 
Total 
 
 
58 
 
100% 
 
42 
 
100% 
 
100 
 
100% 
  
 
 The mode of delivery from above table: 4 and figure :5  shows that among the 100 
neonates studied, 50 (50%) of the neonates were delivered normally, 42 (42%) of 
neonates were delivered by Lower segment Caesarean Section (LSCS) and only 8 (8%) 
of neonates were delivered by assisted vaginal deliveries. 
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 Among 58 cases of EONS, 8 (13.8%) neonates were delivered by assisted vaginal 
ddelivery, 27 neonates (46.6%) were delivered by LSCS and 23 neonates(39.6%) were 
delivered by labour naturale. 
 Among 42 cases of LONS, 15 neonates (35.7%) were delivered by LSCS and 27 
neonates(64.3%) were delivered by labour natural. (Table : 4 and Figure : 5) 
Figure: 5     Mode of delivery among the study group 
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Isolated bacterial pathogens: 
  Out of the blood samples collected from 100 participants, positive blood culture 
was found in 26 cases. The organisms isolated were Klebsiella pneumoniae in 9 neonates 
(35%), Escherichiae coli in 6 neonates (23%), Pseudomonas aeruginosa in 4 neonates 
(14%), Klebsiella oxytoca in 3 neoates (12%), and Staphylococcus aureus in 4 neonates 
(15%). Klebsiella  spp was found to be a most common organism in both early and late 
onset sepsis. ( Figure : 6)  
 
Figure: 6        Distribution of the isolated bacterial pathogens 
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Antimicrobial sensitivity pattern of the isolated organism: 
 Out of  9 Klebsiella pneumoniae isolates, 8  were resistant to third generation 
cephalosporins with Extended Spectrum Beta Lactamase (ESBL) phenotype. It 
contributes 89 % among of Klebsiella  pneumoniae  isolates. Only one isolate was 
sensitive to third generation cephalosporin group. 
 In three Klebsiella oxytoca isolates, two isolates were found to be resistant to third 
generation cephalosporin with ESBL phenotype and remaining one isolate was sensitive 
to third generation cephalosporin 
Figure: 7 
  ESBL among   Klebsiella spp 
 
 Among 12 isolates of Klebsiella  spp, 10 isolates (83%) were resistant to third 
generation cephalosporin with ESBL phenotype. But all 12 Klebsiella spp isolates were 
sensitive to imipenem. (Figure :7) 
ESBL
83%
Non ESBL
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 Out of 6 Escherichiae coli isolates, five (80%) were sensitive to third generation 
cephalosporin. Only one case (20%) was resistant to third generation cephalosporin with 
ESBL phenotype. But all 22 gram negative isolates were sensitive to imipenem and 
cefperazone-sulbactum. Among four Staphylococcus aureus, 3 isolates (75%) were 
methicillin resistant strain (MRSA).  
 Out of 26 bacterial isolates, 21 isolates (81%) were sensitive to amikacin and 
remaining 5 (19%) were resistant to amikacin. Among 26 bacterial isolates, 20 isolates  
(76.9%) were sensitive  to gentamicin and 6 (23.1%) were resistant to gentamicin. Out of 
26 bacterial isolates, 21 isolates (81%) were sensitive to ciprofloxacin and 12isolates 
(46.1%) were sensitive to cotrimoxaxole. 
 
Table: 5                        Sensitivity pattern of all 26  bacterial isolates   
Antibiotics 
K.pneumoniae     K.oxytoca E.coli  P.aerugenosa  S.aureus 
 n=9 %  n=3 % n=6 % n=4 %  n=4 % 
Gentamicin 7 78 2 67 5 83 2 50 4 100 
Amikacin 7 78 2 67 5 83 3 75 4 100 
Cefotaxime 2 22 1 33 5 67 1 25  - - 
Ceftriaxone 2 22 1 33 5 67 1 25 -  - 
Ceftazidime 2 22 1 33 5 67 1 25 -  - 
Co trimoxazole 5 56 1 33 4 67 0 0  2 50  
Ciprofloxacin 7 78 2 67 5 83 3 75 4 100 
Imipenem 9 100 3 100 6 100 4 100 -  - 
Piperacillin-Tazobactum 9 100 3 100 6 100 4 100  - - 
Ampicillin -  - - - - - - - 2 50 
Cefoxitin -  - - - - - - - 2 50 
Erythromycin -  - - - - - - - 3 75 
Clindamycin -  - - - - - - - 3 75 
Vancomycin  - - - - - - - - 4 100 
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 Figure: 8 
Sex wise distribution among blood culture positive cases 
 
 Above figure: 8  show among 26 blood culture positive cases, 15 (57.7%) cases 
were male neonates and it contributes 57.7% of total blood culture positive cases. 
Another 11 cases were female neonates and it contributes 42.3% of total blood culture 
positive cases. There was no statistically significant difference between sex wise and 
culture positive cases. ( ‘p’ valve is >0.05) 
Table: 6 
   Age wise distribution among blood culture positive cases 
SEX  
EONS LONS TOTAL 
No. % No. % No. % 
Male 9 60% 6 40% 15 100% 
Female 6 56% 5 44% 11 100% 
0 2 4 6 8 10 12 14 16
MALE
FEMALE
15
11
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 Out of 26 blood culture positive cases, 15 cases were in the age group of 0-3 days 
and it contributes 57.7% of total culture positive cases. Remaining 11 cases were in the 
age group of 4-28 days and it contributes 42.3% of total blood culture positive cases. 
(Table : 6 and Figure :9) 
Figure: 9 
 
 Among 15 EONS cases, 9 cases (60%) were male neonates and 6 cases (40%) 
were female infants. Among 11 LONS cases, 6 cases (56%) were male newborns and 5 
cases (44%) were female newborns. (Table : 6 and Figure :9) 
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Table: 7  
  Gestational age wise distribution among blood culture positive cases 
 
Gestational  Age EONS LONS TOTAL 
Preterm 9 11 20 
Term 6 0 6 
Total 15 11 26 
 
 
 Above table:7  and figure: 10,  shows that out of 26 blood culture positive cases, 
20 cases (76.7%) were preterm babies and remaining only 6 cases (23.30) were term 
babies. 
 Among 20 preterm babies, 11 cases belong to late onset neonatal sepsis category. 
 In 15 cases of EONS, 9 cases were preterm and another 6 cases  were term 
newborns. All 11 cases of LONS are preterm babies. There was a statistically significant 
association between gestational age and neonatal sepsis cases. ( ‘p’ valve is 0.024). 
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Figure: 10   
 
Table : 8  
  Association of birth weight in positive cases 
Birth Weight EONS LONS TOTAL % 
Normal (≥ 2500 Gms) 3 0 3 11.50% 
Low (< 2500 Gms) 12 11 23 86.50% 
 
 The above table : 8 and figure: 11, shows that 23 (86.5%) blood culture positive 
cases were low birth weight (less than 2500 gm) neonates. Only 3 cases (11.5%) were 
having birth weight above 2500 gms. 
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Figure: 11 
  Birth weight wise distribution wise among positive cases 
 
 
 All 11 (100%) cases of LONS are low birth weight babies. In 15 of EONS, 12 
(80%) cases were having low birth weight and remaining three  (20%) cases were having 
normal birth weight. (Table:8 and Figure:11) There was no statistically significant 
difference between birth weight and culture positive cases. ( ‘p’ valve is >0.05) 
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Table: 9 
Mode of delivery wise distribution among positive cases 
MODE OF DELIVERY 
EONS LONS TOTAL 
No. % No. % No. % 
ASSISTED 2 13.33% 0 0% 2 7.69% 
LSCS 5 33.33% 3 27.27% 8 30.77% 
NORMAL 8 55.33% 8 72.73% 16 61.54% 
TOTAL 15 100% 11 100% 26 100% 
 
 Out of 26 blood culture positive cases, 16 cases (61.54%) delivered by labour 
natural, 8 cases (30.76%) delivered by LSCS and remaining two new born babies 
delivered by assisted vaginal delivery.  
 In 15 cases of EONS, 8 cases (55.33%) delivered by labour natural, 5 cases 
(33.33%) delivered by LSCS and remaining two new born babies were delivered by 
assisted vaginal delivery.  
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 In 11 cases of LONS, 8 cases (72.73%) delivered by labour natural and 3 cases 
(27.27%) delivered by LSCS. There was no statistically significant difference between 
mode of delivery and culture positive cases. (‘p’ valve is >0.05)(Table:9 and Figure :12) 
Figure:12 
Mode of delivery wise distribution among positive cases 
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Table:10 
 
     Neonatal mortality 
  EONS LONS Total 
Death 
n=58 % n=42 % n=100 % 
8 13.8 5 11.9 13 13% 
 
 
 The neonatal mortality rate of present study was 13%  (13 cases). Among these, 
EONS cases were 8 and LONS cases were 5 cases. Out of 8 EONS cases, 5 cases were 
blood culture positive and 3 cases were blood culture negative. Out of 5 LONS cases, 4 
cases were blood culture positive and one case was culture negative. 
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C-reactive protein results in study group: 
 Out of  100 clinically suspected neonatal cases, 40 neonates were  C-reactive 
protein test positive. Out of the 40 positive cases 26 neonates (65%)   were EONS and 14 
cases (35%) were of LONS. (Figure : 13 and Table : 11 ) 
 
Figure:13  
    CRP positive cases in study group 
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Table:   11 
  Association between blood culture results and CRP results 
 
CRP 
Blood Culture 
TOTAL 
POSITIVE Negative 
POSITIVE 14 26 40 
NEGATIVE 12 48 60 
T0TAL 26 74 100 
 
            Detection  of  CRP by  latex agglutination method  was  evaluated  for  its  
sensitivity  and  specificity  against   blood culture     as  reference  test. 
 Sensitivity  =    
𝑇𝑃
𝑇𝑃+𝐹𝑁
 =    
14
26
  × 100 = 53.84% 
 
Specificity  =   
𝑇𝑁
𝑇𝑁+𝐹𝑃
   =   
48
74
  × 100 =64.86% 
 
Positive predictive value  =  
𝑇𝑃
𝑇𝑃+𝐹𝑃
 = 
14
40
 × 100 =35% 
  
Negative predictive value  =  
𝑇𝑁
𝑇𝑁+𝐹𝑁
 = 
48
60
 × 100 =80%. 
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Figure: 14      
   Association between blood culture results and CRP results 
 
  
 
           From   the  above  table : 11  and figure : 14, sensitivity  of  CRP latex 
agglutination test  was  53.84%  when evaluated  against  culture, a  reference  test. 
Specificity of CRP latex agglutination test  was 64.86% compared to culture and positive 
and negative predictive value were 35% and 80%  respectively. According to McNemer’s 
test p value was 0.034. It was found to be statistically significant. 
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Table:12 
 CRP semi quantitative Assay 
 
 
 
 
 
 
 
 Above table:12  Shows, among 40 CRP positive cases, 7 cases were under serum 
CRP level more than 48mg/L category, 5 cases were CRP level in between 24 - 48mg/L 
category, one case was CRP level in between 12-24mg/L category and 26 cases were 
CRP level under 6 -12 mg/L category. 
 Out of 40 CRP positive cases, 14 cases were blood culture positive. Among 14 
culture positive cases,  13 cases due to gram negative organisms ( high titre of serum 
CRP more than 12 mg/L) and one case due to gram positive organism(low titre of serum 
CRP more than 6 mg/L) 
 
 
CRP No. Of cases 
>6 mg/L 27 
>12 mg/L 1 
>24mg/L 5 
>48mg/L 7 
Negative 60 
Total 100 
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Serum Interleukin-6 results in study group: 
 Out of  100 clinically suspected neonatal cases, 39  neonates were  Interleukin-6 
positive. On the 39 positive cases 23 (58.97%) neonates were EONS and 16 (41.03%) 
cases were of LONS. (Figure: 15) 
 
Figure:15 
 
  Serum Interleukin-6 results in study group 
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Table: 13 
     Evaluation of  Interleukin-6 with blood culture 
 
IL-6 
Blood Culture 
TOTAL 
POSITIVE NEGATIVE 
POSITIVE 25 14 39 
NEGATIVE 1 60 61 
TOTAL 26 74 100 
 
            Detection  of  serun Interleukin-6 level  by  ELISA method  was  evaluated  for  
its  sensitivity  and  specificity  against  blood culture,    as  reference  test. 
  Sensitivity  =    
𝑇𝑃
𝑇𝑃+𝐹𝑁
 =    
25
26
  × 100 = 96.15% 
 Specificity  =   
𝑇𝑁
𝑇𝑁+𝐹𝑃
   =   
60
74
  × 100 =81.08% 
          Positive predictive value  =  
𝑇𝑃
𝑇𝑃+𝐹𝑃
 = 
25
39
 × 100 =64.10%  
          Negative predictive value  =  
𝑇𝑁
𝑇𝑁+𝐹𝑁
 = 
60
61
 × 100 =98.36%. 
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Figure: 16 
   Evaluation of  Interleukin-6 with blood culture 
 
 
      From   the  above  table:13  and figure : 16, sensitivity  of  detection of  IL-6 by 
ELISA method was  96.15%  when evaluated  against  culture , a  reference  test. 
Specificity of this test was 81.08% compared to culture and positive and negative 
predictive value were 64.1% and 98.36%  respectively. According to Mc Nemer’s test,    
‘p value’ was 0.001. It was found to be statistically significant. 
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Table:14 
 
    IL-6 Quantitative Assay 
IL-6 assay by ELISA No. Of cases 
Highly Positive (100-200pg/ml) 20 
Moderately Positive (50-100pg/ml) 5 
Weakly Positive  (< 50- 6.25pg/ml) 14 
Negative <6.25pg/ml 61 
Total cases 100 
 
 Out of 39 IL-6 positive cases, 20 cases were under highly positive category (IL-6 
level 100-200pg/ml, OD value 1.21-2.34), 5 cases were under moderately positive 
category (IL-6 level 50-100pg/ml, OD value 0.76-1.20) and 14 cases were weakly 
positive category (IL-6 level 6.25 -50 pg/ml, OD value 0.15-0.75). 
 Among 39 IL-6 positive cases, 25 cases were culture positive (22 cases due to 
gram negative organisms and 3 cases due to gram positive organism). Among 22 gram 
negative neonatal cases, 20 cases have high titre of IL-6 and remaining 2 gram negative 
neonatal sepsis cases  have moderately positive titre of IL-6. All the three gram positive 
neonatal sepsis cases have moderately positive titre of IL-6. 
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6. DISCUSSION 
 Neonatal sepsis is defined as a clinical syndrome of bacteremia with 
systemic signs and symptoms of infection in the first 4 weeks of life. It encompasses 
various systemic infections of the newborn such as septicemia, meningitis, pneumonia, 
arthritis, osteomyelitis and urinary tract infections. Superficial infections like 
conjunctivitis and oral thrush are not usually included under neonatal sepsis. The aim of 
the present study was to detect the bacteriological profile of neonatal sepsis  and 
antibiotic susceptibility pattern of the isolates and also to determine the value of C-
reactive protein and  Interleukin-6 in establishing the diagnosis of neonatal sepsis. 
6.1 Age and Sex wise distribution in study group: 
 The present study shows that out of 100 clinically suspected neonatal sepsis cases, 
male neonates were found to be predominant than female neonates in the ratio of 1.38 : 1.  
Male predominance was also observed in similar studies conducted by YR 
Khinchi AK  et al and Bambala Puthattayil Zakariya et al. This male predominance may 
be due to X-linked immune regulatory gene factor contributing to host’s susceptibility to 
infections in male neonates and also due to the prevalent custom of taking male babies 
preferentially to hospital. 13,28,51 
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 Among 100 study cases, 58 % of cases were under the age group of  0 – 3 days      
( <72 hours) and remaining 42 % of cases were under the age group of 4-28 days. Flora 
Chacha et al  and Sucila Thangam et al  also reported in a similar study where early onset 
neonatal sepsis is more prevalent than late onset neonatal sepsis.15,16 
 In contrast there was a high prevalence of LONS (60%) in the study conducted by 
Neema Kayange et al  in Tanzania among 300 clinically suspected neonatal sepsis 
cases.17 
6.2 Birth weight wise distribution in study group: 
 The current study done with 100 neonates showed 58 neonates had EONS and 42 
had  LONS. Among the reported EONS, 58.6% were of normal birth weight and 41.4% 
were of low birth weight. Among the reported LONS, 14.3% were of normal birth weight 
and 85.7% were of low birth weight. 
 Similar result had been reported in a  comparative study by Rabindra N Misra  et 
al  which showed that out of 75 culture positive cases, 75% of late onset sepsis occurred 
in low birth weight babies.19 A study by  Jun-Ho Wu,  et al  found that more LONS cases 
were present in preterm and low birth weight babies. The immuno compromised state of 
low birth weight  and preterm babies may be  the cause of more  infection in these 
group.82 
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6.3  Gestational age wise distribution in study group : 
 The present study shows that out of 58 EONS cases reported, 17 cases (29.3%) 
come under preterm category and 41 cases (70.7%) come under term category. Among 
42 LONS cases reported, 29 cases (69.1%) come under preterm category and 13 cases 
(30.9%) come under term category. 
 In  similar study by   Bambala Puthattayil Zakariya et al   and Subhranshu Sekhar 
Kar et al  observed increased prevalence of neonatal sepsis among preterm infants when 
compared with term neonates.28,51 
 This increased susceptibility of neonatal sepsis among preterm cases could be 
attributed to inherent deficiency of both humoral and cellular immunity during the first 
week of life.28 
6.4 Distribution of isolated bacterial pathogens among study group: 
 The current study shows that among 100 suspected sepsis cases, blood culture was 
positive in  26 cases (26%). 
 Similar positivity percentage of blood culture had been reported in the study by 
Sucila Thangam et al during April – September 2010 which revealed 28% of positive 
blood culture in 50 samples.16 Another study  by Shrestha R K  et al  in  Nepal medical 
college, Kathmandu, during the period of July 2011 to January 2012 reported similar 
range results of 30.8% of positive blood culture.52 
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 In contrast there  was a high positivity report of blood culture in the study done by 
Rajalakshmi Vishwanathan et al in Kolkatta during March 2009 –August 2010 which 
revealed  46.3% of positive blood culture in 216 samples.27 In contrast low positivity of 
blood culture had been reported in  studies by  Subhranshu Sekar Kar et al  in 
Bhubaneshwar during  the  study  period (2007–2010) which revealed 16.2% of positive 
blood culture in 120 samples.51 
 Reasons for comparative variability in blood culture positivity of various studies 
might be due to administration of prior antibiotics from primary centre, infection with 
anaerobes and effective control in spread of hospital acquired infection.27,28 
 Another reason attributed to the variable positive result may depend on the mode 
of test employed for culture. Commonly used conventional test is time consuming and its 
yield is of significantly low sensitivity when compared to fully automated system which 
is less time consuming and has the benefit of continuous monitoring with high 
sensitivity.28 
 Out of  the 26  isolates,  Klebsiella  pneumoniae  were 9 (35%) , Escherichiae coli 
were 6 (23%), Pseudomonas aeruginosa were 4 (15%), Klebsiella  oxytoca were 3 (12%) 
and Staphylococcus aureus were 4 (15%).  Klebsiella spp was found to be the  most 
common organism in both early and late onset sepsis. 
 In similar studies by Bambala Puthattayil Zakariya et al , Neema Kayange et al 
and Iregu KC et al   results had been reported that  gram negative bacterial infection were 
more prevalent than the gram positive bacteria. Among gram negative organism, 
Klebsiella pneumoniae were predominant isolates.17,28,29 
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 In contrast in a study conducted by Shrestha R K  et al  in  Nepal medical college, 
Kathmandu, during the period of July 2011 to January 2012,  Staphylococcus aureus 
(56.8%)  had been reported as main etiological agent in neonatal sepsis and followed by 
Klebsiella pneumoniae (21.7%), Pseudomonas aeruginosa (13.4%) and others. Highest 
prevalence of Staphylococcus aureus could be attributed to nosocomial infection from 
carrier in relatives and hospital staffs.52 
6.5 Antibiotics susceptibility pattern of isolated pathogens: 
  The present study shows that among 12 Klebsiella  spp, 9 isolates were Klebsiella 
pneumoniae species and remaining 3 isolates were Klebsiella oxytoca. 
 Out of 12 isolates of Klebsiella spp,  83% (10 isolates) were resistant to third 
generation cephalosporin with ESBL phenotype.  
 A similar study done by  Iregu KC et al found that 87% of Klebsiella 
pneumoniae isolates were found to be ESBL producers. Another similar study done in 
North India by Kaistha N et al  found that 88% gram negative isolates were resistant to 
third generation cephalosporin.29,30 
 Based on study done by Bambala Puthattayil Zakariya   et al  in Jawaharlal Nehru 
Institute of Post graduate, Medical Education and Research Puducherry, found that 32% 
of Klebsiella pneumoniae isolates were found to be ESBL producers. It was in contrast to 
present study.28 
Klebsiella pneumoniae is one of most common pathogen profoundly found in 
neonatal intensive care ward environment and various equipment in  neonatal ward. So 
Klebsiella pneumonia causes neonatal septicemia outbreaks in NICU. The third 
87 
 
generation cephalosporin are commonly used empirically in all cases of clinically 
suspected  sepsis in present study centre. It could be the main cause for increased 
incidence of ESBL in the present study. 
But all 12 isolates of Klebsiella spp are sensitive to imipenem. Similar result was 
obtained in the study done by Neema Kayange et al  with about 95% of Klebsiella spp 
sensitive to imipenem. But this drug is costly and not freely available in all health care 
centers in developing countries.17 
The present study shows that among four Pseudomonas aeruginosa, 2 isolates 
(50%) were resistant to gentamicin, 3 isolates (75%) were resistant to third generation 
cephalosporin and one isolate was resistant to ciprofloxacin. But all four isolates were 
sensitive to imipenem and Piperacillin-Tazobactum. This finding similar to study of 
Bambala Puthattayil Zakariya   et al.28  
The current study shows that among four Staphylococcus aureus,  3 isolates (75%) 
were resistant to methicillin (MRSA). In a similar observation made by Ramesh Bhat Y 
et al showed that 79% of staphylococcus aureus isolates were MRSA.22 
A study done by Neema Kayange et al  found that among 149 culture positive 
cases,  32 were Staphylococcus aureus. Out of that 32 Staphylococcus aureus isolates 
28% were resistant to Methicillin. It was in contrast to the present study.17 
Increased prevalence of MRSA may be due to healthy carrier in hospital staffs and 
relatives. 
The present study shows, among 26 bacterial isolates, 21 isolates (81%) were 
sensitive to amikacin.  This study is in accordance with the study conducted by Kuruvilla 
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et al.23 The current study also shows, 21 isolates (81%) were sensitive to ciprofloxacin. 
This finding was  also similar with studies of Neema Kayange et al and Boma AW et 
al.26,88 Increased sensitivity of ciprofloxacin may be due to the practice of that drug  not 
being routinely prescribed to paediatric age group. But according to studies of 
Omokhodion et al  and Boma AW et al revealed that quinolone group was successfully 
and safely useful in neonatal sepsis.88,89 
6.6 Neo natal mortality: 
 The present study shows that 13% (13 cases) of neonatal mortality among study 
group. This mortality rate was low compared to similar studies in Tamilnadu and 
India.23,42 This declining trend of neonatal mortality attributed to effective health care 
management system, strict implementation of infection control protocols in hospital and 
availability of good infra structures and laboratory facilities which all in turn helps in 
early diagnosis and prompt management of neonatal infection.   
6.7 Prevention of drug resistance: 
  The emergence of resistance to the antibiotics should be constantly monitored so 
that the antibiotic cycling policies and the occurrence of the newer resistance pattern in 
the hospital can be determined. There is also a necessity to highlight on the rational use 
of antibiotics and strict adherence to the concept of reserve drugs to reduce the 
inappropriate use of the available antibiotics.  
 Various strategies like hand washing, environmental decontamination, education 
to the health care professionals and continuous surveillance will be helpful in attaining a 
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goal of low level of infection with the multidrug resistant pathogens. The hospital 
infection control guidelines should be formulated strictly to avoid the future spread of 
these multi-drug resistant strains. 
6.8 Age and Sex wise distribution in blood culture positive cases: 
 The current study shows among 26 positive blood culture cases,  male neonates 
were 57.7% cases (15%) and female neonates were 42.3%.   Similar studies by Rekha 
Sriram et al, Kuruvilla et al and Shrestha et al also showed that male neonates were 
predominance in culture positive cases. This may be attributed to single X chromosome 
of male neonates increasing susceptibility to infection14,.23,52 
 Out of 26 blood culture positive cases, 15 cases were in the age group of 0-3 days 
and it contributes 57.7% of total culture positive cases. Remaining 11 cases were in the 
age group of 4-28 days and it contributes 42.3% of total blood culture positive cases. 
Sucila Thangam et al also reported in a similar study where early onset neonatal sepsis 
was more prevalent than late onset neonatal sepsis.16 
6.9  Birth wise distribution in blood culture positive cases: 
  The present study shows that out of 26 blood culture positive cases, 20 
cases (76.7%) were preterm babies and remaining only 6 cases (23.30) were term babies. 
In similar study by   Neema Kayange  et al , Rabindra N Misra et al and Subhranshu 
Sekhar Kar et al  observed increased prevalence of neonatal sepsis among low birth 
weight neonates when compared with normal birth weight neonates.17,19,51 
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6.10 Gestational age wise distribution in blood culture positive cases: 
 In the current study out of 26 blood culture positive cases,  23 (86.5%) blood 
culture positive cases were low birth weight (less than 2500 gm) neonates. Only 3 cases 
(11.5%) were having birth weight above 2500 gms. In similar study done by Boma et al, 
Bambala Puthattayil Zakariya et al, Shrestha et al and Kuruvilla et al observed increased 
prevalence of neonatal sepsis among preterm neonates when compared with term 
neonates. The immuno compromised state of low birth weight and preterm babies may be  
the cause for more  infection in these group.23,28,52,88 
6.11.1.  Evaluation of C-reactive protein against blood culture positive: 
 In the present study, the sensitivity of CRP for proven sepsis (more than 6 mg/ L) 
was 53.84%, its specificity was 64.86%, its positive predictive value was 35.0% and its 
negative predictive value was 80%. 
 In a similar study by Sucila Thangam et al, during April 2010- September 2010 
showed that sensitivity of CRP were 50%, its specificity was 69.4%, its positive 
predictive value was 38.8% and its negative predictive value was 78.1%.16 Another 
similar study done  by Benitz MD  et al from Stanford University of Medicine showed 
that 54.6% of sensitivity on proven neonatal sepsis and 65.5% of specificity  in probable 
neonatal sepsis among 1002 infants.66 
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 Study by Laborada G et al,  in 48 confirmed blood culture positive cases among 
105 suspected neonatal sepsis cases studied, it had been reported that sensitivity of CRP 
was 69%, Specificity was 96%, positive predictive value was 93% and negative 
predictive value was 80%.67Another study by  Doeller H et al, reported  that CRP 
sensitivity 63%, specificity 97%, positive predictive value 83% and negative predictive 
value 91%.68  A study by Kohli-Kochhar R et al,  the sensitivity, specificity, positive 
predictive value and negative predictive value of serial CRP measurements were found to 
be 74.0%, 74.1%, 68.0% and 79.0% respectively in the diagnosis of neonatal sepsis using 
blood culture as the gold standard.75 These three studies showed that slightly higher 
sensitivity compared  to the current study. 
 A study done by Franz A R et al found that 28% of CRP sensitivity, 97% of 
specificity, 81%  of positive predictive value and 77% of negative predictive value.69This 
study showed  lower sensitivity compared to the present study. 
 FloraChacha et al, in there study, showed that the sensitivity and the specificity 
were 90% and75% respectively.15 A study by Nuntnarumit P et al found that sensitivity, 
specificity, positive predictive value and negative predictive value of CRP were 100%, 
94%, 91% and 100% respectively.73 Another study done by Hofer N   et al,  showed that 
CRP  had  95% sensitivity and negative predictive value 98% of  in the diagnosis of 
sepsis.76These three studies showed that high sensitivity of CRP compared to the present 
study. 
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 From these studies, CRP has wide range of sensitivity from 28% to 100%. This  
may be due to different test methodologies and different reference values.  Another 
reasons for low sensitivity and specificity in some  studies may be due to conventional 
blood culture methods  used which has inturn low sensitivity compared to automated 
system.15 
6.11.2 CRP semi quantitative Assay 
 The present study shows, among 40 CRP positive cases, 7 cases were found to be 
with serum CRP level more than 48mg/L category, 5 cases were with CRP level in 
between 24 - 48mg/L category, one case was with CRP level in between 12-24mg/L 
category and 26 cases were of CRP level under 6 -12 mg/L category. 
 Out of 40 CRP positive cases, 14 cases were blood culture positive. Among 14 
culture positive cases, 13 cases were due to gram negative organisms ( high titre of serum 
CRP more than 12 mg/L) and one case was due to gram positive organism(low titre of 
serum CRP more than 6 mg/L). Nora Hofer et al also found that increased CRP level in 
gram negative bacterial infection compared to gram positive bacterial infection.76 
6.12 Evaluation of Interleukin-6 against blood culture positive:  
IL-6 Quantitative Assay 
 The current study shows, out of 39 IL-6 positive cases, 20 cases were of high 
positive category (IL-6 level 100-200pg/ml, OD value 1.21-2.34), 5 cases were of 
moderately positive category (IL-6 level 50-100pg/ml, OD value 0.76-1.20) and 14 cases 
were of weakly positive category (IL-6 level 6.25 -50 pg/ml, OD value 0.15-0.75). 
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 Among 39 IL-6 positive cases, 25 cases were culture positive (22 cases due to 
gram negative organisms and 3 cases due to gram positive organism). Among 22 gram 
negative neonatal cases, 20 cases had high titre of IL-6 and remaining 2 gram negative 
neonatal sepsis cases had moderately positive titre of IL-6. All the three gram positive 
neonatal sepsis cases had moderately positive titre of IL-6. 
 This finding was similar to the study of Laura LR et al which revealed Serum of 
gram negative septicemic cases had increased titre of serum IL-6 level when compared 
with gram positive septicemic cases. Gram negative bacterial endotoxins are potent 
inducer for cytokines production by leucocytes comparing with gram positive bacteria.91 
 In the current study, the sensitivity of IL-6 for proven sepsis was 96.15%, its 
specificity was 81.08%, its positive predictive valve was 64.10% and its negative 
predictive value was 98.36%.  
           Shalini Tripathi et al  investigated the role IL-6 in the diagnosis of neonatal sepsis 
and its correlation with the CRP. The sensitivity, specificity, positive predictive value and 
negative predictive value of IL-6 were 98.4%, 81.2%, 63.5% and 93.5% and those of 
CRP were 41%, 91%, 87%  and 78% respectively.83 
          Similar result were seen with study done by Emine Kocabas    et al  from Istanbul 
University, Turkey showed that IL-6 had 96.2% of sensitivity, 89.7% specificity, 86.2% 
of  positive predictive value and 96.1% of negative predictive value.84 
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     Mehmet et al showed that in 31neonates with confirmed sepsis among 76 neonates 
studied,  the sensitivity, specificity, positive predictive value and negative predictive 
value for IL-6  were 100%, 84.2%, 100% and 81.2%.85 
     Ng PC et al  in their study showed that   IL-6 had sensitivity  of 89%  and 91% of 
negative predictive value for detecting neonatal  infection among 101clinically suspected 
sepsis cases (46 culture proven cases). This is relatively in accordance with present 
study.87 
     A recent study (2013) from Iran, done by Hassan Boskabadi et al  found that IL-6 
had 92.5% of sensitivity, 96.6% of specificity, 97% of positive  predictive value and 
93% of negative  predictive value. The above study shows sensitivity similar to the 
present study.86 
      The current study confirmed the findings of various authors that IL-6 was more 
sensitive than CRP in detection of neonatal sepsis. In neonatal sepsis, serum IL-6 level 
rose earlier than the CRP level.7 So serum IL-6 level detection is mainly useful in early 
detection of neonatal sepsis.  Detection of serum IL-6 level also detects the severity of 
infection and evaluation of the response to antibiotic treatment. 
      Earlier diagnosis of neonatal sepsis by IL-6 evaluation helps to prevent neonatal 
mortality and morbidity and avoid unnecessary initiation of empirical antibiotics which 
in turn helps in preventing drug resistance. 
 
. 
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7. SUMMARY 
 The present study aimed at detecting the bacteriological profile in neonatal sepsis 
and antibiotic susceptibility pattern of isolates in 100 clinically suspected cases and also 
detect the role of CRP and IL-6 in the diagnosis of neonatal sepsis. 
 Out of 100 clinically suspected neonatal sepsis cases, 58 were male babies and 42 
were female babies. Male and Female ratio was 1.38 : 1.    
 Out of 100 cases, Early Onset Neonatal Sepsis was 58 and Late Onset Neonatal 
sepsis was 42. 
 Among 58 cases of EONS, 34 cases (58.6%) have normal birth weight and 24 
cases (41.4%) have low birth weight. 
 Among 42 cases of LONS, 6 cases (14.3%) have normal birth weight and 36 cases 
(85.7%) have low birth weight. 
 Among 58 cases of EONS, 17 cases (29.3%) were preterm babies and 41 cases 
(70.7%) were term babies. 
 Among 42 cases of LONS, 29 cases (69.1%) were preterm babies and 13 cases 
(30.9%) were term babies. 
 Among 58 cases of EONS, 23cases (39.6%) were delivered normally, 27 cases 
delivered by LSCS and 8 cases (13.8%) were delivered by assisted vaginal 
delivery. 
 Among 42 cases of LONS,  27 cases (64.3%) were delivered  normally and 15 
cases (35.7%) were delivered by LSCS. 
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 Out of 100 study cases, 26 cases were blood culture positive. 
 Among 26 clinical isolates, Klebsiella pneumoniae were 9, Escherichiae coli  
were 6, Pseudomonas aeruginosa were 4, Klebsiella oxytoca were 3 and 
Staphylococcus aureus  were 4 isolates. 
 Among 12 isolates of Klebsiella spp, 10 isolates (83%) were resistant to third 
generation cephalosporin with ESBL phenotype. 
 Out of 26 bacterial isolates, 21 isolates (80.8%) were sensitive to amikacin and 20 
isolates  (76.9%) were sensitive  to gentamicin. 
 All 22 isolates of gram negative isolates were sensitive to imepenam. 
 Among four Staphylococcus aureus, 3 isolates (75%) were methicillin resistant 
strain (MRSA). But all four isolates were sensitive to vancomycin. 
 Mortality rate among study group was 13%. 
 Male neonates preponderance (57.7%) were present among  26 culture 
positive  cases . 
 Among 26 culture positive cases, 15 cases (57.7%) and 11 cases (42.3%) 
were  EONS and LONS category respectively. 
 20 cases (76.7%) were preterm and 6 cases (23.3%) were term in culture 
positive cases. 
 23 cases (86.5%) were low birth weight babies and 3cases (11.5%) were 
normal birth weight  babies in culture positive cases. 
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  61.54% of neonates were delivered by normally, 30.77% of were delivered 
by LSCS and 7.69% were delivered by assisted vaginal delivery. 
 Serum CRP level detected by latex agglutination method had 53.84% of sensitivity 
and 64.86% of specificity against blood culture as a reference  test. 
 Positive predictive value and negative predictive value of CRP were 35% and 80% 
respectively. 
 Serum IL-6 level detected by ELISA had sensitivity of 96.15%and specificity of 
81.08% against blood culture as  a reference test. 
 Positive predictive value and negative predictive value of IL-6 were 64.1% and 
98.36% respectively. 
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8. CONCLUSION 
 
 Klebsiella spp were the most common organisms for causing both EONS 
and LONS in the present study. 
 The findings of the present study confirm that the serum level of IL-6 is a 
more reliable marker than the serum levels of CRP. 
 Serum level of IL-6 is also useful in evaluation of response of neonatal 
sepsis to antibiotic therapy. 
  The benefit of measuring serum IL-6 routinely in the diagnosis and follow 
up of neonatal sepsis, is that it reduces neonatal mortality and morbidity 
and also reduces the hospital stay and cost of health care. 
 Neonatal sepsis can be prevented by proper hand washing, proper antenatal 
care, proper aseptic clean labour ward and proper aseptic clean NICU. 
 To strictly adhere to institutional infection control committee’s protocol for 
preventing multi drug resistant organism causing neonatal sepsis.  
 Low birth weight neonates need more care for preventing nosocomial 
infection by multi drug resistant organisms. 
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 ANNEXURE – 1 
 
1. Nutrient agar medium: 
Composition 
Ingredients gram/liter 
Peptic digest of Animal Tissue 5.00 
Sodium Chloride 5.00 
Beef Extract 1.50 
Yeast Extract 1.50 
Agar 15.00 
Twenty-eight grams of dehydrated nutrient agar medium was added to 1000 ml of 
cold distilled water in a flask and boiled to dissolve the medium completely. The medium 
was then sterilized in an autoclave at 1210C and 15 lbs pressure for 15 minutes. The 
sterile media were stored in a refrigerator at 40C for future use. 
2. MacConkey agar medium: 
Composition - Ingredients gram/liter 
Peptone 19.0 
Lactose 10.0 
NaCl 5.0 
Na- Deoxycholate 1.0 
Neutral Red 0.03 
Crystal Violet 0.001 
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Agar 15.0 
Fifty-two grams of dehydrated MacConkey agar medium was suspended in 1000 
ml of cold distilled water and boiled to dissolve the medium completely. The solution 
was then sterilized by autoclaving at 1210C and 15 lbs pressure for 15 minutes. 
3. Blood agar medium 
Composition 
Ingredients gram/liter 
Heart infusion 500.00 
Tryptose 10.00 
Sodium chloride 5.00 
Agar 15.00 
Forty grams of the dehydrated blood agar medium was suspended in 1000 ml cold 
distilled water in a flask and boiled to dissolve the medium completely. It was then 
sterilized by autoclaving at 1210C and 15 lbs pressure for 15 minutes. The autoclaved 
materials were allowed to cool to a temperature of 450C in a water bath. Defibrinated 5-
10% sheep blood was then added to the medium aseptically and distributed to sterile petri 
dishes. Sterile media was stored in refrigerator at 40C for future use. 
4. Muller Hinton agar medium 
Composition 
Ingredients gram/liter 
Beef dehytrated infusion 300 
Casein hydrolysate 17.50 
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Starch agar 17.00 
Agar 17.00 
Thirty-eight grams of dehydrated Mueller Hinton agar medium was suspended in 
1000 ml cold distilled water and boiled to dissolve the medium completely. The solution 
was then sterilized by autoclaving at 1210C and 15 lbs pressure for 15 minutes. The 
autoclaved media was stored in the refrigerator and used later. 
5. McFarland Standard (0.5): 
Reagents: 
Sulphuric acid, 1%: To 100 ml of distilled water,1 ml of conc.sulphuric acid is 
added. Barium chloride, 1.175%: To 100 ml of distilled water, 1.175gm of barium 
chloride is added and mixed well.  
To prepare McFarland 0.5 standards: 
To 85 ml of 1% conc.sulphuric acid, 0.5 ml of Barium chloride is added in a flask 
while constantly swirling the flask. Bring to 100 ml with 1% conc.sulphuric acid. Aliquot 
in test tubes and cap tubes tightly. Store in the dark at room temperature for 3 months or 
longer. 
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ANNEXURE – 2 
Role of C-reactive protein and interleukin-6 in the diagnosis of neonatal sepsis 
     PROFORMA 
 
Name : B/O Mrs.       :      IP No.: 
Age      :        days     
 Sex      :      
Gestational age       :  in weeks   Preterm / Term 
Nature of Delivery    :  Normal/Assisted/LSCS 
Birth weight               :  
Clinical diagnosis    : 
Investigation 
Lab. No.   : 
Blood culture Result : 
Antibiotics Sensitive to : 
Antibiotics Resistance to  :  
 
CRP Result   :    Titre      : 
IL-6 Result   :    O.D Value: 
 
Outcome   :  Recovery and discharge/ death 
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1 1 Female Preterm Normal 2100 N P >6 N 0.1 Cured
2 3 Male Preterm LSCS 1950 N P >6 N 0.14 Cured
3 3 Male Preterm Normal 1900 N P >6 N 0.08 Cured
4 1 Female Preterm LSCS 2000 P K.pneumoniae S S S S S S S S S S P > 48 P 2.24 Cured
5 4 Female Term LSCS 3200 N N N 0.13 Cured
6 2 Female Term LSCS 2800 P S.aureus S S S S S S S S S P >6 P 1.1 Cured
7 4 Male Term Normal 3000 N P >6 P 0.22 Cured
8 4 Male Term LSCS 1900 N N N 0.08 Cured
9 2 Female Term LSCS 3100 N N N 0.11 Cured
10 5 Female Preterm Normal 1900 N P >6 N 0.14 Cured
11 4 Male Term LSCS 1600 N P >6 N 0.07 Cured
12 6 Female Preterm LSCS 1700 N N N 0.09 Cured
13 2 Male Term Assisted 3800 N N N 0.1 Cured
14 2 Male Term Normal 1800 P K.pneumoniae S S R R R S R S S S P > 48 P 1.86 Death
15 4 Female Term Normal 3400 N P >6 P 0.35 Cured
16 2 Female Term LSCS 3900 N N N 0.13 Cured
17 6 Male Preterm Normal 1700 P E.coli R R R R R S R R S S P > 48 P 1.96 Death
18 4 Male Term LSCS 1700 N P >6 N 0.14 Cured
19 4 Male Preterm LSCS 1600 N P >6 N 0.07 Cured
20 3 Male Term Normal 2600 N N N 0.13 Cured
21 3 Female Preterm Normal 2200 N P >6 P 0.48 Cured
22 2 Male Term LSCS 3500 N P >6 N 0.14 Cured
23 3 Male Term Assisted 3500 N P >6 P 0.61 Cured
24 2 Male Term Assisted 3300 N N N 0.08 Cured
25 1 Female Term LSCS 2900 N N N 0.09 Cured
26 2 Female Preterm Normal 2100 N N N 0.1 Death
27 3 Male Term LSCS 2400 N N N 0.11 Cured
28 2 Female Term Normal 2400 N N N 0.13 Cured
29 8 Male Preterm Normal 2200 N N N 0.09 Cured
30 5 Male Preterm Normal 2000 N N N 0.07 Cured
MASTER CHART
31 3 Female Term LSCS 2400 P P.aeruginosa R R R R R S R R S S P >24 P 2.22 Death
32 2 Male Preterm LSCS 2000 P K.pneumoniae S S R R R S S S S S P > 48 P 2.34 Death
33 7 Male Preterm LSCS 2100 P K.pneumoniae S S R R R S S S S S P > 48 P 1.59 Death
34 6 Male Term Normal 2600 N N N 0.12 Cured
35 3 Male Preterm Normal 1900 P E.coli S S S S S S S S S S P >12 P 2.32 Cured
36 3 Female Preterm Normal 2500 N N N 0.13 Cured
37 5 Male Term LSCS 2600 N N N 0.07 Cured
38 3 Female Term LSCS 2700 N P >6 P 0.54 Cured
39 3 Male Term LSCS 2650 N P >6 N 0.08 Cured
40 2 Male Term Assisted 2700 N N N 0.13 Cured
41 3 Male Term Assisted 2900 P S.aureus S S S S S S S S S N P 0.82 Cured
42 5 Male Term Normal 2400 N P >6 N 0.07 Cured
43 3 Female Preterm Normal 2200 N N N 0.12 Cured
44 3 Male Preterm Normal 2000 P P.aeruginosa R S R R R S R S S S N P 1.76 Death
45 7 Male Term LSCS 3500 N N N 0.08 Cured
46 1 Male Term Assisted 3400 N P >6 P 0.62 Cured
47 8 Female Preterm Normal 1800 P K.pneumoniae S S R R R S R S S S P >24 P 2.06 Death
48 3 Male Term LSCS 2400 N N N 0.09 Cured
49 4 Female Term Normal 2300 N N N 0.14 Cured
50 3 Female Term Normal 2000 N P >6 N 0.14 Death
51 2 Male Term LSCS 2800 N N N 0.13 Cured
52 22 Female Preterm LSCS 1700 P K.oxytoca S S S S S S S S S S N P 1.34 Death
53 1 Male Term Assisted 3300 P S.aureus S S R S R R S S S N N 0.07 Death
54 12 Female Preterm LSCS 1900 N N N 0.07 Cured
55 1 Male Term LSCS 3200 N P >6 N 0.08 Cured
56 3 Male Preterm Normal 2400 P K.pneumoniae S S R R R S R R R S P >24 P 1.51 Cured
57 24 Female Preterm Normal 1900 P K.pneumoniae R R R R R S R R S S P > 48 P 1.25 Cured
58 13 Male Preterm Normal 2200 N P >6 N 0.09 Cured
59 3 Female Term LSCS 3200 N P >6 N 0.12 Cured
60 3 Female Preterm Normal 2100 P E.coli S S S S S S S S S S P >24 P 2.34 Cured
61 6 Female Preterm Normal 2400 N N N 0.12 Cured
62 6 Male Term LSCS 2400 N N N 0.14 Cured
63 3 Male Term LSCS 2700 N N N 0.1 Cured
64 4 Male Preterm Normal 2300 N N N 0.1 Cured
65 7 Male Preterm Normal 2100 P S.aureus S S R S R R R R S N P 0.97 Cured
66 2 Male Term LSCS 2800 N P >6 P 0.59 Cured
67 4 Female Preterm Normal 2200 P P.aeruginosa S S R R R S R S S S N P 0.98 Cured
68 3 Female Term LSCS 2700 N N N 0.12 Cured
69 4 Male Preterm Normal 2300 N N P 0.24 Death
70 3 Male Preterm Normal 2100 P K.pneumoniae R R R R R S S S S S N P 1.18 Cured
71 2 Female Term Assisted 3000 N N N 0.13 Cured
72 2 Female Term LSCS 2900 N P >6 P 0.38 Death
73 4 Male Preterm Normal 2100 P E.coli S S S S S S S S S S N P 1.83 Cured
74 4 Male Preterm Normal 2200 N N N 0.07 Cured
75 17 Female Preterm Normal 2000 N N P 0.66 Cured
76 4 Female Term LSCS 2100 N N N 0.07 Cured
77 10 Male Preterm Normal 2400 N N N 0.14 Cured
78 3 Male Term LSCS 2300 N P >6 P 0.21 Cured
79 2 Female Term Normal 2700 N N N 0.13 Cured
80 3 Female Term Normal 2800 N N N 0.13 Cured
81 5 Male Preterm LSCS 2400 N N N 0.14 Cured
82 2 Male Preterm Normal 2000 P K.pneumoniae S S S S S S S S S S N P 2.21 Cured
83 3 Male Term LSCS 2900 N P >6 P 0.32 Cured
84 1 Male Term Normal 3100 N N N 0.07 Cured
85 1 Female Term Normal 2500 N N P 0.43 Cured
86 2 Female Term LSCS 2400 P E.coli S S S S S S S S S S P > 48 P 1.44 Cured
87 2 Female Preterm Normal 1900 N N N 0.08 Cured
88 4 Male Preterm Normal 2100 N N N 0.07 Cured
89 3 Male Term LSCS 2600 N P >6 N 0.1 Cured
90 3 Female Preterm Normal 2200 P P.aeruginosa S S S S S S R S S S N P 1.33 Cured
91 4 Male Preterm Normal 2000 P E.coli S S S S S S R S S S P >24 P 1.93 Cured
92 5 Female Preterm LSCS 2200 P K.oxytoca S S R R R S R S S S N P 1.28 Cured
93 4 Male Preterm Normal 1900 P K.oxytoca R R R R R S R R S S N P 1.51 Cured
94 1 Female Term LSCS 2900 N P >6 N 0.09 Cured
95 2 Female Term LSCS 3000 N N N 0.09 Cured
96 6 Male Preterm Normal 2200 N N N 0.07 Cured
97 4 Male Preterm Normal 2100 N N P 0.54 Cured
98 3 Male Term Normal 3100 N N N 0.13 Cured
99 4 Male Preterm Normal 2400 N N N 0.14 Cured
100 2 Female Term LSCS 2600 N N N 0.09 Cured
